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CHAPTER 1 
INTRODUCTION AND AIM OF THE STUDY 
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Introduction 
Erectile dysfunction (ED) may be considered inability for a sustained penod of time 
to achieve an erection with sufficient rigidity to be able to penetrate or sustain 
penetration until ejaculation Erectile dysfunction may exist although the effector 
organ is physiologically normal, for example in psychogenic ED. Contrary, the 
effector organ may be "clinically functional" yet may have dysfunction compared to 
the state of physiologically normal. In erectile dysfunction, the intracavernous 
pressure is lower than the normal physiologic pressure either from 1) an inability to 
neurologically initiate the changes in the cavernous smooth muscle tone necessary to 
increase arterial inflow and/or to neurologically activate the veno-occlusive 
mechanism (failure to initiate). 2) a deficit in the cavernous artery pressure and 
inflow (failure to fill) and 3) a functional and/or anatomic impairment in cavernous 
veno-occlusive function (failure to store).[l] 
Sexual liberalization and growing public awareness of the abilities of the medical 
profession have caused that an increasing number of impotent patients have 
consulted their urologist during the last twenty years. ED is a common disorder that 
in many men has a profound effect on their well-being. In 1983 Kaplan quoted· 
'The impotent male is without doubt the saddest figure on the stage of human 
drama".[2] 
Identification of the cause is the first step in the successful management of ED. In 
the beginning of this century, psychologic factors were implicated as the main cause 
of impotence.[3] It took the emergence of diagnostic procedures that determine 
specific organic causes of ED to establish organic impotence was a great deal more 
common than the 5% reported by Masters and Johnson in 1970.[4] In 1970 Karacan 
reported that more than 50% of his patients had an organic cause [5] The change of 
nomenclature from "impotence" to "erectile dysfunction" in the 80s heralded the 
definite change of conception of etiology: To date, organic causes of ED are 
considered to be present in up to 50-80% of the patients.[6] As so often in history a 
serendipity triggered this change: in 1982 Virag accidentally caused an erection by 
an injection of a vaso-active substance into the cavernous artery [7] Brindley's 
subsequent systematic research of intracavernous injection of various vaso-active 
substances laid the foundations of modern pharmaco-diagnosis and therapy.[8, 9] 
These advances in knowledge of the pharmacology of erection provided the 
opportunity to investigate the erectile mechanism in vivo and initiated the 
development of new clinical tests to determine specific causes of ED. 
Aim of the study 
There is no universally agreed-on diagnostic approach to the functional evaluation of 
the erectile mechanism. Despite the development of a vanety of clinical tests, it is 
important to realize that all these techniques are more or less invasive. Moreover, 
the techniques differ among investigators, as do the criteria for a normal finding. 
The evaluation of erectile dysfunction is done for practical reasons: to establish a 
diagnosis and to aid treatment selection. The clinician always faces the dilemma: 
How extensive and how aggressive should the diagnostic work up be to achieve this 
goal? Urologists treating impotence are frequently overwhelmed by the multiplicity 
of diagnostic possibilities and techniques. Unfamiliar with the objective and with no 
plan of reasoned action they often engage in time-, energy-, and money consuming 
procedures with inefficient return. Efficacy and side effects of a test are critical 
factors in the selection of a test. This study is a critical evaluation of current clinical 
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diagnostic techniques in an attempt to define reference values and to specify their 
position in a practical diagnostic algorithm for erectile dysfunction. 
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History and physical examination 
Despite the development of new diagnostic tests, history remains the key to the 
diagnosis of erectile dysfunction (ED). Verbally reported data contain diagnostically 
meaningful information that can compare favourably with information collected 
through laboratory techniques.[l] The initial evaluation begins with precision of the 
motive of the visit and expectations of the patient and his partner. The patient may 
expect a certificate of organicity of his impotence to suppress guilt towards the 
partner, rather than treatment. The nature of the presented complaint has to be 
established: maximal rigidity and duration of erections, particulary nightly and 
morning erections, erections during masturbation, foreplay and with other partners 
are of interest. Is penetration possible? Loss of erection just after starting sexual 
intercourse may be related to arterial insufficiency or veno-occlusive dysfunction. 
Once the nature of the presented complaint has been established, the evaluation 
is directed at identifying psychologic and organic factors that may adversely affect 
erectile performance. Classic features suggesting primary psychogenic factors include 
an acute onset, which may be related to a specific event (except for a traumatic 
event or vascular accident), and a history of normal erections with other partners or 
with masturbation. However, if such questions are used to "eliminate" the existence 
of organic factors, misdiagnosis may result. The reason lies in the fact that partial 
organic impairment may not yet be evident during masturbation or sleep but will be 
manifested in less than optimal conditions. In contrast, an insidious, progressive loss 
of erectile capabilities with consistent change in rigidity of or ability to sustain 
morning-, coital-, or masturbation-related erections, is usually indicative of primary 
organic disease.[2, 3] 
Table 1: Vascular risk factors 
Hypertension Hyperlipidemia 
Smoking Diabetes mellitus 
Coronary heart disease Cerebral and peripheral vascular disease 
Vascular surgery Perineal or pelvic trauma or surgery 
Radiation therapy to the pelvis. 
Diminished libido may be caused by an endocrine disorder or may be a reaction 
to the erectile dysfunction. The history should include questions exploring the 
patients' relationship with his partner, any economic or social stress, and the 
possibility of affective disorders, history of psychopathology or psychological 
counselling. The medical history also should include the identification of underlying 
vascular risk factors (table 1). A history of known neurological disease (e.g., multiple 
sclerosis or spinal cord injury), pelvic surgery (e.g., radical cystoprostatectomy or 
proctocolectomy), concomitant changes in bladder and bowel function or penile 
sensation, and disorders associated with peripheral neuropathy (e.g., alcoholism and 
diabetes mellitus) may suggest an underlying neurologic cause. Because of the 
association between drugs and impotence, a detailed history of the patients' 
medications should be obtained. Hypertension has long been associated with the 
development of ED. Most investigators have attributed the problem to 
antihypertensive medications. Recently, Hsieh found that most of the ED seen in 
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the presence of hypertension is due to atherosclerosis rather than to the use of 
antihypertensive drugs.[4] 
The physical examination of the patient with ED will be unrewarding with regard 
to etiological clues. Generally, one looks for the development of normal secondary 
sex characteristics, as they are a gross index of androgen stimulation. Hypogonadal 
disorders will usually go together with loss of libido. The neurologic examination 
should be directed to the sacral dermatomes and should include sensory testing of 
the penis and perineum and an evaluation of the bulbocavernosus reflex. The 
vascular examination involves assessment of the abdominal aorta (aneurism?), the 
arteries in the penis and lower extremities. The penis should be examined for 
phimosis and fibrosis (Peyronie's disease).[5] 
Endocrinologie evaluation 
Serum testosterone levels vary widely in normal men, and are related to the 
episodic secretion of LH.[6] It comes in short spurts, twelve times a day, with 
increments preceded some two hours by a release of LH. The mean concentration 
shows a clear diurnal variation, with a high concentration in the morning.[7] As both 
shorter and longer plasma variations occur, it should be understood that a single 
plasma testosterone determination may be misleading. 
The development of secondary sex characteristics is dependent on the occurrence 
of androgen production and secretion, although maintenance of these features are 
not androgen dependent. The necessity of androgens required for normal sexual 
function has been demonstrated clearly in animal experiments.[8] In humans, the 
role of androgens in male sexuality has been determined from clinical data on 
medically (e.g. by the use of cyproterone acetate, flutamide and estrogens) and 
surgically castrated individuals and in hypogonadal states. Surprisingly, these studies 
in hypogonadal men demonstrate the potential for retention of sexual capacity. 
Recent double-blind controlled studies of androgen replacement in hypogonadal 
males have provided a key to the apparent contradiction between data suggesting 
that erection is androgen dependent and that erectile capacity is retained in 
castrated men. Androgen replacement results in a recrudescence of libido (e.g., 
sexual interest and activity), mood elevation, and restoration of ejaculation.[9-ll] 
The physiologic capacity for erection is less sensitive to androgen withdrawal than is 
sexual interest and activity. In assessing erectile function, one must distinguish 
between sleep erections, spontaneous daytime erections, erections in response to 
audio-visual stimuli and those erections in response to tactile stimuli. Spontaneous 
erections (diurnal and nocturnal) are markedly reduced in hypogonadism and are 
restored by androgen replacement. In contrast, erections in response to erotic films 
continue with or without androgen replacement.[12, 13] Apparently, the central 
processes that lead to spontaneous erections are androgen dependent, while the 
mechanisms leading to erection in response to external erotic stimuli remain intact 
despite androgen deprivation. 
Low testosterone levels associated with low LH levels are suggestive of 
hypogonadism due to a hypothalamic or pituitary defect and require further 
evaluation of the pituitary gland. An elevated LH level suggests primary 
hypogonadism, due to testicular failure. A low testosterone level can be associated 
with hyperprolactinemia, whereas an elevated testosterone level may suggest 
hyperthyroidism.! 14, 15] 
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For a long time, hyperprolactinemia has been accepted as a cause of male sexual 
dysfunction.[16] In the process of evaluating men with ED, the urologist occasionally 
will see a patient with elevated serum prolactin levels. Its prevalence ranges between 
1 and 16%.[17-19] However, what is the significance of such a finding? If the serum 
prolactin level is elevated markedly and accompanied by low testosterone, FSH and 
LH, then the patient should be evaluated further to rule out a pituitary adenoma. 
This may be accomplished by obtaining a CT-scan of the head with intravenous 
contrast medium. In 15% of those patients a pituitary adenoma is found. Those men 
invariably complain of decreased libido with poor quality erections but all have 
normal nocturnal erections as registered by Rigiscan The lack of radiological 
evidence however, is not unusual in the presence of micro-adenomas, which are 
beyond the resolution of the CT scanner [20] 
Medication-induced hyperprolactinemia is not uncommon (29%).[19] The serum 
elevations are usually moderate and not accompanied by changes in other 
hormonal parameters. Drugs associated with hyperprolactinemia are: estrogens, 
Cimetidine, metoclopramide, alpha-methyldopa, Imipramine, dompendone, cannabis, 
haiopendol and phenothiazine Elevation of prolactin is due to direct stimulation of 
the anterior pituitary by the drug or drug-induced blockade of the inhibitory effect 
of dopamine on the lactotroph [21] Chronic renal failure as the cause for 
hyperprolactinemia may be found in up to 6% of the patients [19] Such patients also 
may have evidence of gonadal failure. In the majority of patients (48%) the 
hyperprolactinemia is idiopathic, which usually means that it is an isolated finding on 
hormonal measurements that has been substantiated by a repeated assay [19] Recent 
reports indicate that emotional stress and tobacco smoking may cause mildly 
elevated serum prolactin levels [22] 
The mechanism whereby hyperprolactinemia induces impotence remains 
conjectural Reducing the serum level of testosterone is not the only mechanism 
whereby prolactin inhibits erectile function. The administration of exogenous 
testosterone in the presence of hyperprolactinemia does not improve sexual 
function.[23] Thus, prolactin appears to have a central effect on sexual performance. 
Because none of the patients in a series of 1.236 had abnormal hormonal 
parameters in isolation from abnormal serum testosterone, it is obvious that 
hormonal screening of ED can be accomplished with measurement of serum 
testosterone levels alone.[19] If the level is abnormal a more comprehensive 
endocrine evaluation becomes necessary.[24] 
Nocturnal penile tumescence and ngidity testing (NPTR) and audiovisual sexual 
stimulation (ASS) 
In the differential diagnosis of ED it is considered important to establish whether 
penile erection can occur under any circumstance [25] There are various approaches 
to this question. Traditionally, patients self-report is used as the primary basis. 
However, this method is considered unsatisfactory, since patients' self-report is 
notoriously unreliable in establishing penile erections either in sexual or nonsexual 
circumstances (i e. morning or night erections). Although reports by the patient and 
partner still form a significant component in the evaluation of male sexual 
dysfunctions purely physiological measures of sexual functioning have assumed a 
more dominant role in the etiological categorization of ED. Thus, identification and 
measurements of erectile response to audiovisual sexual stimulation and of the 
nightly cycle of penile erections are considered a major breakthrough in the 
assessment of ED. 
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The earliest references to nocturnal erections appear in the 40s.[26] In the 50s, 
Aserinsky noted that the nightly cycle of erections resembled the cycle of dreaming 
and rapid eye movement sleep and later reported that the erection cycle in fact 
coincided with rapid eye movement sleep.[27, 28] Fisher et al. later demonstrated 
that 95% of the rapid eye movement periods were accompanied by penile 
erection.[29] Karacan found that nocturnal penile tumescence (NPT) is present from 
birth to senescence in healthy male subjects, although age does influence some NPT 
variables (for example total tumescence time per night or average length of 
tumescence cycle).[30] Since in 1970 NPT was suggested to be used in the diagnosis 
of ED to distinguish between organic and psychogenic causes, some important 
problems have been raised with regard to the use of NPT.[31] 
One of these problems concerns the interpretation of NPT recordings. It is clear 
that there are large inter-individual differences in circumferential changes during the 
sleep cycle, and that such differences may be related primarily to anatomical 
variations. This is to say that a circumferential increase may represent a full erection 
in one man but the same change still may produce a flaccid state in another. 
Therefore, the full NPT evaluation of ED has been defined for clinical purposes to 
include axial rigidity measurements made at or near the points of maximum penile 
circumference. Initially the measurement of axial rigidity required a test that 
awakened the patient with subsequent loss of the erection. Therefore, the 
introduction of a technique that permitted measurement of penile rigidity 
continuously throughout the night without disturbing sleep appeared to be an 
important improvement. 
An approach to this problem initially focused on the use of bands placed around 
the penis that could be broken by the force from the circumferential expansion 
during erection. The first attempt used postage stamps pasted together to make a 
snug-fitting ring around the flaccid penis.[32] A more refined approach used the 
Velcro-attached Snap-Gauge, which has 3 separate bands each calibrated to 
withstand different forces before breaking.[33] However, these methods could not 
provide quantitative information about nocturnal penile erections. This problem was 
solved with the development of the Rigiscan". 
This device is able to perform a reliable continuous registration of NPT and 
rigidity (NPTR) and can be used as home monitoring tool. According to Dacomed 
normal males have three to six erections with a duration of 10-15 min per 8-h 
session. Rigidity less than 40% is translated as "non-rigid", 40-70% as "buckling will 
occur, but erection may be "stuffable" while > 70% is translated as 
"non-buckling/rigid". Furthermore occurrence of dissociation = normal base readings 
with abnormal tip rigidity, and uncoupling = normal tumescence with abnormal 
rigidity (base and tip) should be encountered.[34] 
Apart from the validity, the reliability has been a matter of concern. For reliable 
nocturnal recordings, at least 2-3 night sessions are necessary. However, Lemaire et 
al. indicate that for clinical practice — provided that only the optimal results are 
considered as conclusive - registration of several nights can be considered as non-
contributory. He found that three night monitoring only slightly increases the rates 
of optimal NPTR and of clearly inconclusive (due to sleep disorders) suboptimal 
NPTR's.pS] 
Although Rigiscan* has considerable methodological advantages in comparison to 
simple tumescence monitoring, recent data suggest that NPTR may be influenced by 
sleep problems not routinely assessed in the home NPTR evaluation. Specifically, in 
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patients with frequent REM-related respiratory events (i.e., apneas or hypopneas) 
NPTR is often disrupted by arousals or movements that resulted in brief periods of 
detumescence.[36] A second theory-based challenge to the use of NPTR is the 
possibility that psychological factors may result in impaired NPTR in the absence of 
organic disease.[37-39] For example, from studies of normal potent males it has 
emerged that full erections may not occur despite a normal sleep pattern. 
Apparently, NPTR may be suppressed in REM periods in which the dreams have a 
high anxiety content.[40-42] Furthermore, depression may produce diminished NPTR 
responding.[43] Kirkeby analyzed NPTR recordings of controls and found absence of 
rigidity sufficient for vaginal intromission in 13-40% of the volunteers, even if 
registration was performed for several nights.[44] 
Several investigators have reported that the mechanisms that underlie nocturnal 
erections may be physiologically and qualitatively different from those that mediate 
erotically stimulated, diurnal erections. Rosen postulates that the neural pathways 
subserving spontaneous daytime erections and NPTR diverge from those involved in 
sexual erections.[41] Moreover, spontaneous but not erotically stimulated erections 
are directly dependent on testosterone and prolactin.[45, 46] 
Because of the concerns regarding validity and reliability as well as the financial 
and time expenditure NPTR demands, recently much interest has developed in 
audiovisual sexual stimulation (ASS).[47] Functional sexual potency can be assumed 
when penile erection occurs during ASS. However, in a comparative study, Chung 
found that the compatibility ratio of NPTR and ASS is markedly low in a group of 
patients with psychogenic etiologies, probably due to severe erotic excitement 
inhibition.[48] Although we do not know whether the mechanism of erotic erection 
is different from that of nocturnal erection, ASS would seem to be an appropriate 
initial screening test for erectile failures: the presence of a full erection as a result 
of ASS proves that the psycho-neurovascular sexual response mechanism is intact 
functionally and that the cause of the ED most likely is of psychosocial nature and 
obviates the necessity for NPTR recordings. However, the development of standards 
for stimulation is necessary, to avoid inconsistency of results due to the 
heterogeneity of techniques.[49] NPTR can be used additionally in the diagnosis of 
ED with the following reservations: The presence of NPTR sufficient for vaginal 
intromission proves waking erectile capability only in the absence of a neurological 
disorder. The absence of nocturnal erections with rigidity sufficient for vaginal 
intromission is found frequently in normal males, even if registration is performed 
for several nights. 
Neuro-UroPHysiologic Investigation (NUPHI) 
During the past two decades concepts and understanding of neurogenic impotence 
have undergone important changes. Until the early seventies the mere history of 
neurological disease, surgical intervention in the pelvis or metabolic disturbances in 
a patient with complaints of ED sufficed for the conclusion of the impotence being 
neurogenic. The introduction of sophisticated neuro-urophysiological investigatory 
techniques paved the way for a more precise and detailed neurological evaluation of 
the functional status of the uro-genital tract. These newly developed techniques only 
partly confirmed the old pathophysiological concepts: neuro-urophysiological 
investigations proved not only to yield normal results in patients with obvious 
neurological disease, thus underlining the importance of a multi-causal and multi-
disciplinary approach, but also to detect abnormalities in unsuspected patients. 
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The classical concept of neuro-physiologic mechanisms responsible for obtaining 
and maintaining penile erection is that of an integration of mental and physical 
impulses in the central nervous system resulting in coordinated motor outflow along 
autonomic and somatic neural pathways to the uro-genital effector organs.[50, 51] 
Erotic fantasy and sexual stimuli of various origins (tactile, audio-visual, gustatory 
and olfactory) arouse psychological mechanisms, which on their turn generate 
neurological impulses in the autonomic motor tracts (pelvic nerves) necessary for 
cavernous smooth muscle relaxation. In this concept direct mechanical stimulation of 
penile sensory nerves and the reflex activation of pelvic floor muscles are of 
supportive value.[52-55] 
The ideal neuro-urophysiological investigatory technique would be one that 
objectively and quantitatively evaluates the functional status of all parts of the 
neurological network involved in obtaining and maintaining penile erection. 
Therefore, a series of tests has been developed, each of which reflects a specific 
part of the network. Basically there are two methods for neuro-urophysiologic 
investigations. The first method involves registration of spontaneous electro-
myographic activity in the musculature of the uro-genital apparatus: The striated 
pelvic floor muscles reflect the function of somatic efferent neural tracts,[56, 57] 
whereas the cavernous smooth muscles yields information on autonomic efferent 
tracts.[58, 59] The second method is the registration of central and peripheral 
responses to external stimulation. Electrical, mechanical and visual stimuli are used 
for stimulation; patients' subjective report as well as recording equipment are used 
for registration. Sacral reflex arcs (somatic and autonomic) are assessed by recording 
the latency of reflex responses measured in the anal sphincter after electrical 
stimulation of the dorsal penile nerve (bulbocavernosus reflex: BCR),[60, 61] and 
after stimulation of the urethro-vesical junction (urethro-anal reflex: UAR).[62, 63] 
BCR provides information on somatic sensory and motor nerves; UAR provides 
information on autonomic sensory nerves and on somatic motor nerves. 
The sensory pathway from the penis to the cerebral cortex is evaluated by 
measurement of the cortical evoked potential after electrical stimulation of the 
dorsal penile nerve (pudendal evoked potential: PEP).[64, 65] Other techniques of 
testing sensory nerves are: measurement of the sensory threshold of the urethral 
mucosa for electrical stimulation,[66] and of the penile skin for vibration (penile 
biothesiometry).[67] 
The completion of the neuro-urophysiologic diagnostic armamentarium in the 
sense of techniques to evaluate the autonomic motor innervation of the uro-genital 
tract has been initiated by Wagner, who succeeded to record a cavernous 
electromyogram (penis-EMG):[58] By means of a needle electrode introduced in the 
cavernous body, a baseline intermittent firing activity is recorded. After audio-visual 
sexual- and/or pharmaco-stimulation, with increasing tumescence and rigidity a 
decrease of cavernous smooth muscle activity is noted. Only recently, single potential 
analysis of cavernous electric activity (SPACE) has been introduced in the diagnosis 
of cavernous autonomic neuropathy and cavernous smooth muscle dysfunction.[59] 
Obviously, both techniques are still in their infancy and need further sophistication. 
In the future the use of motor evoked potentials after magnetic stimulation of the 
cerebral cortex and the sacral spinal cord can be expected for the evaluation of 
penile motor neural pathways. Application of a strong, time varying magnetic field 
on the appropriate site of the central nervous system (cortex, sacral conus) enables 
measurement of evoked responses in striated and smooth muscles.[68, 69] 
The diagnosis of erectile dysfunction: review of tbc literature 21 
Vascular evaluation 
Alternations in the penile in- and outflow tract are thought to be the most frequent 
causes of organic ED.[70] The two principal causes of obstruction within the penile 
inflow tract are atherosclerotic vascular disease and traumatic arterial occlusion.[71-
76] The principal causes of cavernous veno-occlusive dysfunction are insufficient 
smooth-muscle relaxation and anatomical or functional abnormality of the cavernous 
body resulting in decreased erectile-tissue compliance.[77] Insufficient relaxation may 
occur in anxious men with excessive adrenergic constrictor tone, such as in 
psychogenic impotence, or in patients with damaged parasympathetic dilator nerves, 
such as in neurogenic ED. Decreased erectile tissue compliance may be caused by 
structural changes in the fibro-elastic components of the trabeculae, specifically the 
amount and type of collagen, as a result of aging, diabetes mellitus, vascular risk 
factors and surgery\trauma to the penis.[78-81] 
Penile hemodynamics 
Cavernous smooth muscle relaxation results in penile erection through an increase 
of arterial inflow to and a restriction of venous outflow from the cavernous bodies. 
Relaxation of the helicine artery smooth muscle increases blood flow to the 
sinusoids. Simultaneous relaxation of the trabecular smooth muscle dilates the 
sinusoids and enables expansion of the erectile tissue against the tunica. The 
compression of the subtunical venules by the expanded erectile tissue against the 
tunica is the mechanism restricting venous outflow from the corpora (figure la and 
b). The highest flow rates occur within the first minute after onset of erection, 
depending on the individual's arterial health.[82] During erection, intracavernous 
pressure increases to levels of mean systemic arterial blood pressure (80- 100 mm 
Hg), with higher pressures generated by perineal muscular contractions.[54] 
Figure la Figure lb 
Transection through the cavernous body in flaccid (la) and erect (lb) state 
Anatomy 
The paired internal pudendal artery arises from the internal iliac artery and runs 
outward and downward, leaving the pelvic cavity to enter the gluteal region, where 
it curves around the ischial spine to enter the ischiorectal fossa. At this point it runs 
in the pudendal canal (Alcock's canal), on the inner surface of the internal 
obturator muscle. It then pass downward and inward, piercing the urogenital 
diaphragm to divide into its terminal branches. One of these branches is the 
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common penile artery that divides into 4 branches: one to the proximal urethral 
bulb, one to the corpus spongiosum, one to the corpus cavernosum (cavernous 
artery) and one to the dorsum of the penis (deep dorsal artery). The cavernous 
artery provides blood to the cavernous body through multiple resistance helicine 
arteries that open directly into the cavernous sinusoids. Venules located in the 
subtunical space between the periphery of the erectile tissue and the tunica provide 
venous outflow from the corpora via the peripheral lacunae. Several tests have been 
designed to evaluate the cavernous vascular status (Table 2). 
Table 2 Tests to evaluate the cavernous vascular status 
Phanmacotest 
Pharmaco-ultrasonography (duplex scanning) 
Selective pudendal pharmaco-angiography 
Dynamic pharmaco-cavernosometry-graphy 
Peno-Brachial Index (PBI) 
Nuclear medicine imaging 
Pharmacotest 
In 1986, the pharmacotest has first been described as diagnostic tool for evaluating 
penile circulation.[83] To date, this test precedes other more elaborate vascular 
diagnostic studies, such as duplex ultrasonography, penile blood pressure 
determinations, nuclear medicine imaging and angiography.[84-87] 
Three different agents are used for intracavernous injection testing: papaverine, 
the combination of papaverine-phentolamine, and Prostaglandine El (PGEl). 
Theoretically these substances are used to substitute for the neurotransmitter to test 
the arterial, venous and sinusoidal mechanisms and to differentiate vascular from 
psychogenic and neurogenic ED.[88] A positive test, defined by a rigid erection 
implies a normal vascular status, and neurologic and psychological factors should be 
considered. If only partial, shortlived, or no erection results, than hemodynamic 
impairment may be suspected. However, the failure to produce an erection may be 
due to excessive adrenergic constrictor tone as a result of anxiety.[89] Thus, a 
negative result from a single pharmacotest is inconclusive. On the other hand, the 
risk of developing a prolonged erection lasting more than 6 hours is considerable in 
unselected patients. 
A pharmacotest, using 50 mg of papaverine may be false negative in 25% of 
non-selected impotent men, whereas prolonged erection may occur in 5.3%.[90] In a 
multi-centre study comparing papaverine, papaverine / phentolamine and PGEl, 
PGEl emerged as the most accurate diagnostic drug, with an overall erection rate 
of 74% and a prolonged erection rate of only 0.1%.[90] Recently, in reviewing the 
literature, Jiinemann found the following frequencies of prolonged erections during 
diagnostic work-up: papaverine 9.5%, papaverine/phentolamine (n=2914) 5.3% and 
PGEl (n=1284) 2.4%. The most endangered group of patients likely to experience 
pharmacological prolonged erection is the non-vascular group.[91] From those data 
PGEl emerges as the drug of choice in the pharmacological diagnosis of ED. 
Non-responders bear a high probability of a vasculogenic etiology with a 
predominance of veno-occlusive insufficiency. However, up to 15% of the 
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non-responders may show a predominance of psychogenic factors despite the lack of 
erection. 
Pharmaco-ultrasonography (duplex scanning) 
In 1985, Lue introduced duplex ultrasonography as a non-invasive tool in the 
evaluation of penile circulation.[87] With duplex ultrasonography, it is possible to 
visualize size and dilatation of cavernous arteries, structural changes of the 
cavernous body as well as the blood velocity in the cavernous artery. Knowledge of 
these parameters provides an estimate of penile blood flow in response to 
intracavernous injection of vaso-active agents and is a useful indicator of arterial 
inflow capacity and venous outflow. Furthermore, pathological conditions such as 
vascular calcifications or fibrosis associated with Peyronie's disease can be 
located.[92] 
Figure 2 Longitudinal ultrasonographic image of the cavernous body through the plane 
of the artery 
Selective pudendal pharmaco-angiography 
Genestie and Romieux first performed selective penile angiography on impotent 
patients.[93] Selective pudendal angiography is used to study the architecture of the 
penile arterial system and to date, with the introduction of non-invasive tests, is 
performed in selected cases of healthy patients suspected of having isolated arterial 
disease, in whom surgical repair is considered. The study is utilized to define the 
anatomic pattern of arterial occlusive disease and allows the planning of an 
appropriate vascular surgical approach. Satisfactory angiographic evaluation requires 
precise demonstration of the penile arterial supply from the aortic bifurcation to the 
tip of the penis. The identification of the dorsal artery and the cavernous artery is 
important as a guide to the type of anastomosis required for revascularization. Four 
major technical improvements have greatly modified penile angiography: 
intracavernous injection of vaso-active agents, inducing maximal vasodilatation, new 
low-osmolality contrast media, preventing pain, DSA and new catheters, that enable 
this procedure to be performed with one single femoral artery puncture.[94] 
Dynamic pharmaco-cavemosometry-graphy 
Cavernosometry and cavernosography are the primary modalities available for 
detection and mapping of veno-occlusive dysfunction in men with erectile failure. 
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They usually are reserved for patients being considered for arterial and / or venous 
surgery. Since Newman introduced infusion cavernosometry in 1964, many different 
techniques have been described.[95] The methods evaluate the degree of cavernous 
outflow resistance and therefore, to date, it is generally accepted that they should 
always be performed after smooth-muscle relaxation by intracavernous injection of 
vaso-active agents.[70] 
Venous outflow resistance during pharmaco-cavernosometry is assessed by 
determining the relationship between the intracavernous flow rate of saline required 
to create or sustain an erection or by infusing saline to a suprasystolic 
intracavernous pressure and determining the rate of the fall in pressure after the 
infusion is stopped. A rollerpump is utilized to regulate the infusion flow rates.[96] 
In 1988, Puech-Leao introduced an alternative technique to evaluate veno-
occlusion: gravity-cavernosometry. Instead of utilizing a rollerpump to regulate the 
infusion flow rate, a simple infusion set is used to generate a steady infusion 
pressure above mean arterial systemic pressure. The closer intracavernous pressure 
equals infusion pressure, the better the status of the veno-occlusive mechanism.[97] 
Figure 3 High selective penile angiography. 1: a. pudenda, 2: a. dorsalis penis, 3: a. 
cavernosa 
An alternative method of functional evaluation of the cavernous artery is by 
measuring its occlusion pressure, at the time of pharmaco-cavernosometry: A 
Doppler ultrasound transducer probe is placed over the left and right lateral aspects 
of the cavernous body at the base of the shaft to record the respective cavernous 
artery pulsatile flows. For each cavernous artery, the probe then is fixed in place 
while flow is recorded on the multichannel strip chart recorder. The cavernous body 
pressure is elevated above the cavernous artery systolic occlusion pressure by 
heparinized saline infusion. The infusion is terminated as the cavernous artery 
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pulsatile flow disappears As the cavernous body pressure diminishes, the cavernous 
artery pulsatile flow is re-established. The cavernous artery systolic occlusion 
pressure is defined as the cavernous body pressure when cavernous artery pulsatile 
flow is re-established. This value is compared with the brachial artery systolic 
occlusion pressure recorded during this phase Based on observations in a normal 
physiologic group, Goldstein defined reference values by the gradient between the 
brachial and cavernous systolic occlusion pressures: A difference of over 36 mmHg 
is considered abnormal cavernous artery hemodynamic function.[98, 99] 
If cavernosometry suggests that significant veno-occlusive dysfunction is present, 
the anatomical site of leakage can be demonstrated by intracavernous infusion of 
contrast (cavemosography). Cavernosography should be performed under the same 
conditions of smooth-muscle relaxation, with intracavernous infusion of contrast 
material. In veno-occlusive dysfunction, veins are visualized draining from the 
cavernous body during erection, in the glans, corpus spongiosum, the deep dorsal, 
cavernous and crural veins 
Peno-Brachial Index (PBF) 
FBI was introduced in 1971, when Gasiceli first used a Doppler device for evaluating 
penile blood flow.[100] The penile brachial index (FBI) is the ratio between systolic 
penile and brachial pressures measured by the use of Doppler techniques. An 
individual is considered to have a normal FBI when the index is greater than 0.75, 
an intermediate value if it is 0.75 to 0 60 and an abnormal value if it is less than 
0.60.[85] Although, initially the FBI became a very popular value for diagnosing 
artenogenic impairment in association with ED, it soon turned out to suffer from 
several shortcomings:[88] 
1) Sclerotic vessels may give high pressure readings but in reality arterial flow may 
be minimal. 2) Since the standard method to acquire FBI does not include 
ultrasound visualization, it is not possible to be certain from which artery the 
Doppler signal is being derived, even if one carefully attempts to isolate a single 
vessel When FBI is calculated from the maximal pressure of any penile artery 
without excluding the dorsal or urethral artery, it is assumed implicitly that the 
dorsal or urethral artery pressures accurately reflect cavernous artery pressures. 
Schwartz found a poor correlation between FBI and arteriography when all penile 
arteries were included in the FBI calculation. When only cavernous arteries were 
included the correlation improved. He concluded that it is not possible to use the 
FBI value as a means to predict cavernous artery integrity.[101] 3) Even if 
cavernous artery Doppler signals can be isolated effectively with direct visualization, 
it remains uncertain whether the cavernous artery pressure acquired in the flaccid 
state accurately reflects penile artery pressures acquired in the excited, early 
tumescence state. 
Nuclear medicine imaging 
The intravenous radioisotope penogram study was introduced and developed by 
Shirai.[102] However, the investigators did not use the test for penile erection and 
therefore it has not found widespread application for diagnostic purposes. Recently, 
Kim performed radioisotope erection penography to observe the hemodynamic 
changes of the penis during pharmacologically induced erections.[103] 
Although intracavernous injection of vaso-active agents seemed to be an important 
improvement in the functional evaluation of vasculogenic ED, this technique is also 
still subject to vanous degrees of psychogenic inhibition. 
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Treatment of prolonged erection 
The most common complication during the diagnostic work-up and especially during 
pharmaco-cavernosometry is the pharmacologically induced prolonged erection. Not 
all pharmacologically induced prolonged erections necessitate a specific treatment 
owing to the fact that penis detumescence generally occurs within a few hours. Lue 
demonstrated that in pharmacologically induced prolonged erection, blood gas values 
manifest inadequate blood supply to the erectile tissue after 6 hours.[104] 
Especially at the time of cavernosometry the risk of prolonged erection is high 
because the patient receives high doses of vaso-active drugs. To prevent this, the 
patients are not allowed to leave the fluoroscopy room before the erection has 
subsided. In case erection recurs after drainage of the cavernous body, aspiration of 
cavernous contents is repeated to decrease cavernous body pressure and an 
adrenergic agonist is injected intracavernously to induce cavernous smooth muscle 
contraction, effective venous drainage and restriction of arterial inflow. We use 10 
μg of adrenaline. The correct dose is prepared by adding 1 mg adrenaline to 100 ml 
normal saline, to make a solution of 10 Mgr a m adrenaline/1 ml. A standard 2 ml 
syringe is utilized to deliver 1 ml (10 μgr) intracavernously. After a compressive 
bandage has been applied, the penis is fixed to the innerdorsal site of the thigh. 
After 30 minutes the bandage is removed. In case an erection has recurred the 
procedure is repeated. The blood pressure and pulse should be monitored during 
and following adrenergic agonist administration. 
The use of penile biopsies in the detection of cavernous disease 
Although clinical diagnostic tests have improved the understanding of the 
pathophysiology of penile erection, methods to assess the function of the cavernous 
body directly are still not at our disposal. Recently, much attention has been focused 
on (ultra)structural investigation of cavernous tissue as tool in the diagnosis of 
disease of the cavernous body. [105-107] 
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Abstract 
Combined duplex scanning and pharmaco-stimulation is generally used for evaluating 
penile circulation in men with erectile dysfunction. Peak flow velocity, acceleration, 
dilatation of cavernous artery, volume increase of cavernous body and inducibility of 
erection are commonly measured parameters. This study was performed to assess 
the value of those variables. In addition, an alternative index for quantifying 
Doppler waveform was studied: resistance index (RI). 
Reproducibility of papaverine-induced erection, peak flow velocity and acceleration 
was disappointing. Comparison of duplex-parameters before papaverine-stimulation 
showed no statistically significant differences in patients with or without 
papaverine-induced erection. After papaverine-stimulation however statistically 
significant differences were noted for acceleration, RI and penile volume. RI 
appeared to be most valuable in evaluating penile hemodynamic changes after 
papaverine-stimulation. The assessment of arteriogenic factors does require repeated 
recordings of RI in the early phase of erection. 
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Introduction 
The development and application of sonographic equipment has experienced 
tremendous growth since Gaskell introduced a Doppler device for evaluating penile 
blood flow in 1971.[1] The early Doppler systems were nondirectional, i.e. no 
distinction could be made between blood moving away from the probe and blood 
moving toward the probe. Nor could a distinction be made between the cavernous 
and dorsal arteries. The systems could only detect the presence of flow and were 
used in measurements of penile arterial pressure.[2, 3] 
In 1980, the pulsed-Doppler device was introduced for evaluating erectile 
dysfunction.[4] That device was able to detect the direction of blood flow and use 
various depths of sampling. Coupling of the device to a spectral analyzer made it 
possible to obtain a printed Doppler velocity waveform of the vessel under study. In 
the latest development, the duplex-Doppler, blood flow velocity waveform analysis 
and ultrasonographic imaging are combined to assess anatomical and functional 
parameters of penile circulation simultaneously. 
Today, duplex scanning, performed after induction of maximal penile circulation 
by intracavernous pharmaco-stimulation has gained general acceptance as the 
standard in the evaluation of penile circulation.[5] It has replaced the measurement 
of penile blood pressure in the initial work-up of a patient with erectile dysfunction. 
Measurement of the penile brachial pressure index (PB1) may not be accurate for 
several reasons. Sclerotic vessels may give high pressure readings but in reality 
arterial flow may be minimal. In most instances the dorsal artery, not the cavernous 
artery, is scanned. PBI is measured in the flaccid state, so in no way can the 
functional capability of arterial flow during erection be estimated.[6] 
Theoretically, direct measurement of blood flow (volume per unit time) in the 
cavernous artery in the latency and tumescence phases of erection should be the 
best indicator of arterial capacity.[6] In clinical practice however, this is impractical 
and therefore several parameters have been used for quantifying penile blood flow: 
Acceleration, peakflow velocity, arterial dilatation, visible pulsatility of the cavernous 
artery and increase of penile volume.[4-7] Of those parameters, peakflow velocity 
and arterial dilatation have found widespread clinical application. In this study we 
investigated reproducibility and discriminating value of those variables. In addition 
we studied acceleration, penile volume and resistance index (RI), a basic pulsatility 
index, also known as the Pourcelot index.[8] 
Materials and methods 
We evaluated 91 consecutive men, age between 23 and 77 years old (mean, 54 
years) who came to the office with complaints of erectile dysfunction. We took 
detailed histories, and the patients underwent physical examination and 
pharmacologic erection testing with injection of papaverine hydrochloride into the 
cavernous body. 
Papaverine test 
The standard initial injection dose in all patients was 50 mg. but patients suspected 
having neurogenic erectile dysfunction were given only 12.5 mg. After injection, each 
patient was asked to massage his penis for 2 minutes to distribute the drug within 
the cavernous tissue. Ten minutes after injection, the response was evaluated by 
inspection and palpation. The response was considered positive if the erection angle 
with the patient standing was at least 90° or if, in the case of a long penis, rigidity 
was considered adequate by palpation.[9] In all patients the papaverine-test was 
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repeated during duplex scanning with the same dose of papaverine. However, penile 
massage during duplex scanning was not performed. 
Duplex scanning 
A commercially available linear-array black and white duplex scanner with an 
imaging frequency of 7.5 MHz and an axial resolution of 0.1 mm was placed 
longitudinally on the fienile shaft as proximal as possible in the infrapubic region, 
twice before and 3 and 5 minutes after papaverine-stimulation. The base line filter 
frequency was defined at 50 Hz. Doppler flow studies were performed with a pulsed 
Doppler system operating at a frequency of 3.75 MHz. Spectral analysis of the 
signals obtained was used to display the blood flow velocities in the cavernous artery 
as a function of time. 
after pharmacostimulation 
time [ms] 
Figure 1 Diagram of flow velocity pidse in the cavernous artery before and after 
papaverine stimulation. A = acceleration time, В = peak flow velocity and С = 
diastolic flow velocity 
Several charactenstics of its maximal envelope were generated (figure 1): (A) 
acceleration time; (B) maximal flow velocity or peak flow velocity; (C) diastolic flow 
velocity. This yielded information on the fastest-moving blood cells in the vessel 
which produced the greatest Doppler-frequency shifts in both systolic and diastolic 
phases. We used this information to compute acceleration: peak flow velocity per 
unit acceleration time and resistance index (RI):[8, 10, 11] 
(peak flow velodtvWdiastolic flow velocitvi 
peak flow velocity 
As shown in figure 1, RI is defined by the formula (b-c)/b. 
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Simultaneous B-mode ultrasonography provided visualization of the cavernous 
arteries and bodies. Twice before and 6 minutes after papaverine-stimulation the 
diameters of the cavernous arteries and bodies were measured by placing the probe 
longitudinally on the mid-penile shan, first left then right, allowing a longitudinal 
section through the plane of the artery. Length of the cavernous body was measured 
in centimeters with a ruler from the infrapubic region to the coronal sulcus. Penile 
volume was computed: (»74) (diameter of right cavernous body)(diameter of left 
cavernous body)(length of penile shaft). Ten minutes after injection, erectile 
response was evaluated by inspection and palpation. Reproducibility of blood flow 
parameters was assessed with two consecutive recordings before papaverine-
stimulation; the probe was positioned anew each time. 
Statistical analysis 
In the statistical analysis, the coefficients of variation between patients and between 
measurements were compared. Reproducibility of papaverine-testing was assessed by 
comparing erectile response in the office and at the time of duplex scanning. 
Patients were classified into three groups: Group 1: Patients with 
papaverine-inducible erection in the office and at the time of duplex scanning. 
Group 2: Patients with papaverine-inducible erection in the office but not at the 
time of duplex scanning. Group 3: Patients with no erection on either occasion. 
Simultaneous statistical comparison of the three groups with the test of 
Kruskal-Wallis involved six variables — peak flow velocity, acceleration, HI, arterial 
dilatation, volume increase of the cavernous body and age — and was followed by 
comparison of each pair of groups with the Wilcoxon 2 sample test. 
Results 
Measurements of Doppler parameters (peak flow velocity and acceleration) with 
repositioning of the probe each time yielded substantially greater variation than 
measurements obtained with B-mode ultrasonography (diameter of cavernous artery 
and body), as shown in table 1. 
Table 1 Mean ±_ SD of measurements and standard deviation of variation between 
men and between measurements 
Measurement 1 
Measurement 2 
SD# of variation 
between men 
SD of variation 
between measurements 
Peak Velocity 
(cm/s) 
11.7 + 5.9 
10.3 + 3.8 
2.7 (24%)· 
3.3 (30%) 
Acceleration 
(cm/s/s) 
304 + 152 
289+168 
65 (22%) 
105 (35%) 
Diameter of 
cav. artery 
(mm) 
1.25 + 0.24 
1.24 + 0.22 
0.22 (17%) 
0.08 (6%) 
Diameter of 
cav. body 
(mm) 
13.9 + 3.2 
14.1 + 3.5 
3.2 (23%) 
1.1 (8%) 
# Analysis of variance : random effects model. 
* Coefficient of variation (SD/mean X 100%). 
Thirty of 63 patients (48%) had papaverine-inducible erection in the office and 
had no erection at the time of duplex scanning. There were no patients, who did 
not respond to papaverine in the office, and who subsequently developed a rigid 
erection, tested again at the time of duplex scanning. 
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The correlation between papaverine-inducible erection and age is statistically 
significant. Further statistical analysis showed no significant correlation between age 
and duplex variables for group 1, 2 and 3, except for arterial dilatation. 
After papavenne-stimulation, for the duplex variables statistically significant 
differences between the 3 groups were noted in acceleration (p= 01), RI (ρ=.02) 
and increase in penile volume (p < 0 01) In further statistical analysis with the 
Wilcoxon 2 sample test those differences were demonstrated between groups 1 and 
3 and were not noted between groups 2 and 3 
It is noteworthy that the higher RI's were encountered in group 1 (the vascular 
"normal" group), suggesting the lowest flow in that group at the time of 
measurement(table 2) Comparison of parameters measured at 3 and 5 minutes 
after papavenne-stimulation showed no significant differences in either group 
The increase in penile volume was significantly different between groups 1 and 2 
No statistically significant differences between the groups were noted in peak flow 
velocity Dilatation of cavernous artery showed an approximately significant 
difference between groups (1, 2) and 3 (p= 10) 
Table 2 Summary of measurements in three groups 
Group 1 
<n=33) 
Group 2 
(n=30) 
Group 3 
(n=28) 
Kruskal Wallis 
Ρ value 
Peak flow 
velocity 
(cm/s) 
Acceleration 
(cm/s/s) 
Resistance 
index 
Dilatation (X) 
cavernous artery 
Increase (X) 
peni le vol une 
Age (years) 
Before 
Before 
10 
11 3 • 4 3 
27 6 • 11 5 
27 0 i 11 β 
310 • 189 
358 • 162 
Ш • 238 
0 70 + 0 H 
0 7« i 0 17 
29 • 22 
520 • 338 
48 í 10 
111*45 
25 0 • 11 8 
21 0 • 8 6 
309 • 146 
265 • 124 
240 i 130 
0 65 * 0 14 
0 66 • 0 13 
27 • 19 
331 • 238 
53 • 13 
10 3 « 4 4 
23 6 » 13 8 
26 0 * 17 8 
284 • 80 
259 + 139 
271 i 158 
0 62 + 0 09 
0 64 * 0 11 
19 + 18 
302 + 187 
58 • 9 
0 53 
0 20 
0 14 
0 98 
0 01* 
0 14 
0 02* 
0 05* 
0 10* 
0 007* 
0 01« 
0 Minutes after papaverine stimulation 
* Significant difference 
Results are nean + SO 
Classification 
of patients 
Papaverine-induced rigidity 
Office Piytenscanning 
Group 1 
Group 2 
Group 3 
Yes 
Yes 
No 
res 
No 
No 
Discussion 
Although examination of penile circulation by the combination of duplex scanning 
and papavenne testing has found widespread clinical application for evaluating 
erectile dysfunction, a standard procedure of measurement, variables to be measured 
and reference values have not been defined clearly and differ between investigators 
Theoretically, the combination of duplex scanning and papaverine testing can be 
useful in differentiating artenal disease (failure to fill) and cavernous disease (failure 
to store). Today, peak flow velocity, acceleration, dilatation of the cavernous artery, 
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volume increase of the cavernous body and pharmaco-inducibility of erection are 
commonly measured parameters. In this study, reproducibility of Doppler 
parameters was disappointing in the flaccid state. The different outcome of 
measurements should be attributed to variables associated with the process of 
obtaining the tracings. As demonstrated before in other vascular beds, two factors 
associated with placement of the probe may influence the shape of the flow velocity 
waveform: 
1) The angle between Doppler beam and axis of blood flow As it is changed toward 
0°, the amplitude of the wave (peak flow velocity) increases, although its shape 
remains unchanged (figure 2a).[12] Thus, peak flow velocity in the sample volume 
can only be recorded accurately if the probe-vessel angle is adjusted correctly. 
Unfortunately, that is difficult in the cavernous artery, because of the anatomy of 
the infrapubic region. With regard to the skin, the course of the cavernous artery 
changes from parallel to transverse. As the vessel runs transverse to the direction of 
the probe, the quality of visualization of cavernous structures impairs and hampers 
precise assessment of the angle between the Doppler beam and the vessel(figure 3). 
2) Arteriosclerosis If a Doppler waveform is recorded in an arterial stenosis a high 
peak blood flow velocity is measured, because of the occurrence of jetflow in such a 
stenotic segment. Thus, a relatively high peak flow velocity can be associated with 
arteriosclerosis and impaired penile circulation (figure 2b).[12] The use of a 
parameter that does not depend on the absolute value of peak flow velocity should 
avoid those problems. We used resistance index(RI) as such a parameter. The 
formula RI = {(peak flow velocity)-(diastolic flow velocity)}/(peak flow velocity) 
Alters out the probe-vessel angle and suppresses the effect of jetflow.[8] 
Similar to other studies we found that reproducibility of papaverine-induced 
erection is poor, although the same dose of papaverine was used consequently.[13, 
14] There were no patients not responding to papaverine in the office, who 
subsequently developed a rigid erection when tested again at the time of duplex 
scanning. Failure of papaverine-induced erection during duplex scanning must be 
due to lack of privacy during the test inducing stress and anxiety. The addition of 
phentolamine to papaverine or the use of PGEl might reduce the interference of 
those factors. Obviously every effort should be made to minimize psychological 
factors. 
It should be emphasized that difficulties in assessing diagnostic value of 
papaverine-induced duplex scanning was due not only to poor reproducibility of 
parameters, but also to the lack of reference values in the literature. Hitherto, 
duplex studies of penile circulation have not been performed in men with normal 
erectile function, probably because intracavernous pharmaco-stimulation in controls 
has met with reluctance in investigators. Therefore, we had to define our reference 
group on the basis of the outcome of papaverine-induced erection, based on the 
presumption that papaverine-inducible erection is correlated with normal 
hemodynamic events. This approach deserves a word of caution: though a positive 
papaverine-test rules out hemodynamically significant arterial disease, erectile 
response is not an absolute measure for penile blood flow. On the one hand a 
positive reaction to papaverine-stimulation does not rule out a (compensated) 
impairment of penile arterial circulation, on the other hand a negative erectile 
response does not prove arterial insufficiency, but might be caused by veno-occlusive 
dysfunction or psychogenic inhibition. 
To minimize misinterpretation as much as possible, we classified patients 
according to the outcome of two papaverine-tests in three groups. Patients with 
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papaverine-inducible erection in the office and during duplex scanning were 
considered to have the best penile circulation and have the least psychogenic 
inhibition.[6] Patients with papaverine-induced erection in the office but not at the 
time of duplex scanning probably had more psychogenic inhibition than group 1, 
though they also might have had mild vascular disease making their erection more 
vulnerable to psychogenic inhibition. Group 3 with no erection on either occasion 
was certainly the group containing patients whose impotence results from severe 
vascular abnormalities. However this group also probably contained the most 
psychogenically inhibited patients. Thus, it is obvious that classification of patients on 
the basis of papaverine-induced erection as was done in this study does not allow 
for exact definition of reference values of duplex parameters. The results merely 
may indicate that parameters like acceleration, RI and penile volume are more 
accurate than peak flow velocity and arterial dilatation, (table 2). The results also 
indicate that penile circulation in the inhibited patients (group 2) mimics penile 
circulation in patient with compromised blood vessels (group 3). 
Dilatation of the cavernous artery seems to be a discriminating parameter 
between psychogenic inhibition (group 2) and compromised blood flow (group 3), 
however on closer analysis it appeared to be significantly correlated to age, 
suggesting that cavernous dilatation is merely a function of age. 
In our hands RI seemed to be the best parameter to assess penile hemodynamic 
changes after papaverine-stimulation. Is this observation compatible with the current 
understanding of the pathophysiology of penile circulation? [15] In most patients 
(90%), no diastolic blood flow was observed in the flaccid state, thus RI is 1.00. At 
the onset of erection, the smooth muscles of the sinusoids and the helicine vessels 
relax; this causes a decrease in cavernous vascular resistance, which facilitates 
diastolic flow and leads to a decrease in RI. As long as intracavernous pressure is 
lower than diastolic blood pressure and as long as the resistance vessels are open, 
diastolic flow persists and RI remains below its initial level of 1.00. Therefore, in the 
early phases of erection (latency and tumescence), RI depends on the rate of 
arteriovenous shunting through the resistance vessels (helicine arteries). In rigidity, 
intracavernous pressure rises to a level above diastolic bloodpressure, causing 
cessation of diastolic blood flow and returning of RI to its initial value (RI=1.00). 
Closer analysis of the values of RI in this study shows that the lowest RI's were 
measured in patients who obtained no rigid erection (group 2 and 3) and that no 
significant differences could be demonstrated between the measurements at 3 and 5 
minutes after papaverine stimulation. At first sight these results are in conflict with 
current concepts of penile circulation. One would expect the lowest RI in the 
non-vasculogenic group (group 1), because the better the blood flow, the lower the 
RI. This apparent conflict may be explained by the timing of the measurements (3 
and 5 minutes after papaverine-induction). At that time patients of group 1 are in 
the rigidity-establishing phase of erection resulting in a decrease of diastolic flow 
and an increase of RI. In groups 2 and 3 no rigidity is obtained resulting in 
persistent diastolic flow and decreased RI. Therefore, to evaluate penile arterial 
circulation we recommend continuous monitoring of RI in the early phase of 
erection in order to measure the lowest RI and the time of its occurrence. 
Prolonged decrease of RI is indicative of venous leakage. At the time of preparation 
of this manuscript we began a study in which we measure RI every minute after 
papaverine-stimulation in a group of men with normal erectile function. In the 
future we will be able to describe normal values of RI as a function of time. 
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Figure 2 (a) As the angle between Doppler beam and axis of blood flow is changed 
towards (f, the amplitude of the wave (peak flow velocity and diastolic flow velocity) 
increases, although its chape remains unchanged (b) In arterial stenosL· a high peak 
blood flow velocity is measured, because of the occurrence of jetflow (I) Behind the 
stenosis the waveform is dampened (2) 
Figure 3 Schematic representation of the anatomy of the infrapubic region and course 
of the cavernous artery. Bending of the cavernous artery makes precise assessment of the 
probe-vessel angle difficult 
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Nelson and associates demonstrated that ultrasonographic determination of penile 
volume can be useful in the assessment of penile circulation when he calculated 
penile volume as the product of corporal surface area and length of penile shan. [7] 
This could be confirmed in our study, by using the ultrasonographically assessed 
diameters of the left and right cavernous body as an alternative for corporeal 
surface area, and the equation penile volume = (W4)(diameter left)(diameter 
right)(length). Both calculations provide relative measures of penile volume and 
their results should be comparable. In contrast with Nelson, who did not find a 
greater volume increase in the group with rigid erection, we found that a rigid 
erection (group 1) is associated with a significant greater increase in corporal 
volume (table 2). Differences in patient selection might explain the apparent 
conflict. In Nelson's study, 82% of patients with a poor response to papaverine were 
assigned to a group with veno-occlusive disease; in our study only 30% had 
veno-occlusive disease and up to 52% had inhibited erection. 
It is well documented that the incidence of erectile dysfunction increases with 
age.[16] In our study, comparison of groups 1 and 3 (p < 0.01) suggests a causal 
relationship between the effect of papaverine-stimulation and age (table 2). Further 
statistical analysis showed no significant correlations of duplex parameters and age, 
except for dilatation of the cavernous artery. 
Conclusions 
Combined Doppler waveform analysis, real time visual display (duplex scanning) of 
the cavernous artery and body and intracavernous papaverine-stimulation might be 
used for assessing penile circulation. Certain errors and artifacts are introduced by 
current methodology of measurement and choice of parameters. Psychogenic 
inhibition of papaverine-induced erection is a source of misinterpretation. The 
patients in this study who were classified on basis of papaverine-inducibility of 
erection could not be used to define normal penile circulation. Therefore we were 
not able to assess reference values for the parameters of blood flow, that were used. 
We found that the dynamic state of stimulated penile circulation is best represented 
by the resistance index (RI). However accurate timing of measurement is of utmost 
importance to detect penile arterial insufficiency. We recommend obtaining RI 
continuously in the early phase of erection. At the time of preparation of this 
manuscript we started to assess multiple RI after papaverine-induction in a group of 
men with normal erectile function, to answer the question "what is normal?" 
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Editorial comment on T h e value of combined papaverine testing and duplex 
scanning in men with erectile dysfunction" 
Duplex scanning in combination with pharmaco-testing seems to have become the 
most important clinical diagnostic work-up for differential diagnosis of erectile 
dysfunction. Therefore, it is important to prove the validity and reproducibility of 
the duplex evaluated parameters in order to distinguish between vascular and non­
vascular impotence. Penile arterial peak flow measurements as well as diameter 
changes after papaverine application, first introduced by Lue and colleagues, have 
proved helpful but not enough to differentiate arteriogenic impotence. Therefore, 
the paper written by Meuleman and colleagues is an exceptionally important 
contribution to duplex scanning in impotent men. The comparison of different 
parameters, including peak flow velocity, penile volume increase, arterial dilatation 
and resistance index has not been performed up till now and clearly shows the 
advantages of particularly the drawbacks of each parameter. It is important to 
mention, we achieved exactly the same results, that peak flow velocity and arterial 
diameter changes alone do not enable us to discriminate between vascular and 
nonvasculogenic impotence. 
The most important contribution Meuleman's paper makes is the incorporation of 
the resistance index for duplex analysis. From our own experience, I can state that 
measurement of systolic and diastolic penile blood flow seems to be the most 
important factor for blood flow evaluation and allows the most accurate analysis of 
penile blood flow. The foremost question is " what are the threshold parameters for 
normal and impotent men?" This brings me to the most critical point in this paper 
where the authors conclude that, based upon their findings, the resistance index in 
the normal group was higher in comparison to the pathological group owing to the 
latest flow in that group at the time of measurement. This finding is contradictory to 
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current concepts of the hemodynamic mechanisms during erection. From animal as 
well as clinical studies, we know that the highest arterial inflow after pharmaco 
stimulation is measured during the early phase of erection (tumescence phase) with 
complete relaxation of the corporeal smooth muscle and a decrease in peripheral or 
corporeal resistance. The contradictory findings of the authors could be due to the 
fact that they only use papaverine hydrochloride monosubstance which has been 
found to be less than 50% "potent" for inducement of an erection in comparison to 
the combination papavenne/phentolamine or PGE1. In our series, the calculated 
resistance index in patients with psychogenic erectile failure was always below 0 68 
and any impairment of arterial penile flow led to a resistance index greater than 
0.68. 
Coming to a final conclusion, Meuleman's paper is one of the very few critical 
articles that clearly demonstrate the insufficiency of our diagnostic work-up in 
impotent men. Old and new parameters should always be critically evaluated and 
standardization of normal and threshold values as well as the method itself is the 
foremost task of the future. 
K.-J Junemann 
Reply by the authors 
In our study the resistance index (RI) in the normal group was indeed higher in 
comparison to the pathological group. 
On first sight this finding may be contradictory to current concepts of penile 
hemodynamics. On closer examination however this apparent conflict may be 
explained by the timing of measurements (3 and 5 mm after papaverine-mduction). 
At that time, patients of the normal group have passed the phase of maximal blood 
flow (first minute) characterized by a low RI. At 3 and 5 minutes after papaverine 
stimulation they are already in the rigidity-establishing phase, resulting in a decrease 
of diastolic flow and thus an increase of RI. 
Patients of the pathological group however will not obtain rigidity, resulting in 
persistent diastolic flow and thus low RI, at 3 and 5 mm after papaverine induction. 
E.J.H. Meuleman et al. 
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Abstract 
Duplex ultrasonography is important in the diagnosis of vasculogenic erectile 
dysfunction. The purpose of this study was to measure the ultrasonographic 
parameters of cavernous blood flow in different phases of penile erection. We 
examined 44 volunteers with normal erectile potency. Doppler spectra of the 
cavernous artery were obtained in a time-dependent manner following 
intracavernous administration of papaverine. 
Following intracavernous pharmacological stimulation, the Doppler spectrum alters 
according to a specific pattern indicating the different hemodynamic phases of 
erection. Peak flow velocity and acceleration time, measured in the early post-
injection phase may be used to grade arterial inflow, the difference between 
resistance index in the pre- and late post-injection phase may be used to estimate 
veno-occlusive function. Reference values are defined. 
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Introduction 
Increase of arterial inflow and restriction of venous outflow are important 
determinants of penile erection. Inflow may be impaired by atherosclerotic changes 
in the cavernous inflow tract. Veno-occlusive dysfunction may occur when there is 
an anatomical or functional abnormality of the cavernous body. In the initial 
diagnostic work-up of erectile dysfunction, the ultrasonographic assessment of 
hemodynamic significant impairment of arterial inflow and/or veno-occlusive 
dysfunction is important in selecting patients for vascular surgery. High surgical 
success rates are reported in patients with isolated obstruction in the pudendal tract 
in combination with an intact veno-occlusive mechanism. Success rates in patients 
with multilevel arterial disease and venous leakage are significantly lower.[l] 
In 1985, Lue introduced duplex ultrasonography as a non-invasive tool in the 
evaluation of penile circulation.[2] To date, the method has not found the 
widespread clinical application which was expected at its introduction. Possible 
explanations are related to high costs of the equipment, difficulties in mastering the 
technique, operator-dependency of the method and lack of standardization.[3] An 
important limitation of conventional (black and white) duplex ultrasonography is that 
flow velocity information is not displayed in the image and is obtained only from an 
area where flow is expected. 
The advent of color flow imaging (CFI) allowed not only high-resolution imaging 
of vessel and tissue features, but also enabled display of flow characteristics 
throughout the image. This simplified the detection of vessels and allowed precise 
correction of the Doppler angle, resulting in rapid and accurate acquisition of 
Doppler data.[4] With CFI the ease of operation and the reliability of the technique 
increased, setting the stage for real-time monitoring. This seemed of clinical 
importance since Lue described different hemodynamic phases of erection in a 
papaverine-stimulated animal model.[5] 
Based on our experience in more than 300 patients, we analyzed Doppler spectra 
and B-mode color images in 44 volunteers with normal erectile potency, obtained in 
a time-dependent manner following the intracavemous administration of papaverine, 
and defined parameters of arterial inflow and venous outflow. 
Materials and Methods 
Between July 1989 and January 1990 forty-four volunteers (mean age + sd, 56 ± 11 
year) were examined at the clinical vascular laboratory of the University Hospital 
Nijmegen. 
The volunteers were recruited from a population seeking urological advice because 
of various urological complaints such as prostatodynia, prostatism and infertility. All 
had a history of normal erectile potency, having the ability to achieve sufficient 
erectile rigidity for penetration and sustain penetration until ejaculation. Nine 
volunteers (20%) had a history associated with general atherosclerosis, 10 volunteers 
(23%) used tobacco. Twenty-five (57%) had a history without vascular risk-factors. 
Informed consent was obtained from all participants. 
Color flow imaging (CFI) and Doppler spectrum analysis 
A commercially available duplex-scanner with color flow imaging possibilities was 
used. B-mode color images and Doppler spectra were obtained with a 5 MHz 
linear-array transducer. B-mode ultrasonography provided visualization of the 
cavernous arteries and bodies. Electronic cursors were used to measure the outer 
diameters of the cavernous arteries in the longitudinal projection in the proximal 
penile shaft. An axial resolution of 0.1 mm could be obtained. Color imaging was 
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then performed to display blood flow in the cavernous arteries. By using the color 
image as a guide to the location and direction of flowing blood, the Doppler sample 
volume cursor (sample volume = 1 mm) was placed accurately in the cavernous 
artery as proximal as possible in the infrapubic region, and the Doppler angle 
correction cursor was adjusted to match the correct axis of flow. The resulting 
angle-corrected Doppler spectrum was displayed on the monitor, and acceleration 
time, peak flow velocity, and end-diastolic flow velocity were measured directly from 
the recorded velocity tracing. That information was used to calculate the resistance 
index (RI)(figure 1):[6] 
„y _ (peak flow velocitvWdiastolic flow velocity) 
(peak flow velocity) 
a = peak flow velocity 
b = diastolic flow velocity 
с = acceleration time 
RI -
a - b 
cm/s 
time 
Figure 1 Doppler spectrum analysis 
Study protocol 
All examinations were performed by the same investigator and technician. The male 
was supine and the penis with the dorsum exposed. To assess the alternations of 
cavernous blood flow in different phases of erection the study protocol was designed 
to perform duplex ultrasonography in a time-dependent manner following the 
intracavemous injection of 12.5 mg (0.25 ml) undiluted papaverine hydrochloride. A 
low dose of papaverine was used to minimize the risk of prolonged erection. 
Four phases were defined (figure 2): Phase 1: before administration of 
papaverine. Phase 2a: first 5 minutes following injection. Phase 2b: between 5 and 8 
minutes following injection. Phase 2c: 11 minutes following injection and after 
massage of the penis. 
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Phase 1 
Before administration of papaverine the diameter and the Doppler spectrum of both 
cavernous arteries were obtained. Because arterial diameters and the Doppler 
spectra were very alike for the left and right side, the left-right averaged data were 
used to describe this phase. 
Phase 2a 
In the first 5 minutes following injection, Doppler spectra of the cavernous artery 
with the strongest response were sampled at one minute intervals. The artery with 
the strongest response was chosen for sampling because accurate scanning of both 
arteries at 1 minute intervals appeared to be infeasible. The validity of unilateral 
sampling was supported by the fact that comparison of the bilaterally obtained 
phase 1 Doppler spectra showed no significant differences. 
Phase 2b 
Between 5 and 8 minutes after injection the diameter of both cavernous arteries 
were measured and a Doppler spectrum was obtained. 
Phase 2c 
In order to obtain optimal erectile response, the men were asked to massage the 
penis and the investigators left the room for 3 minutes. Between 11 and 15 minutes 
after injection the phase 2c Doppler spectrum was recorded, and erectile response 
was evaluated by inspection and palpation. 
time schedule 
1 2a 2b 2c 
« —•< •« •« • p h a s e 
Ш (2) (D © © © Ш _ © 
t 1 2 3 L 5 8 11 I5min 
papaverine 
inject 
n= measuremenl number 
• Doppler spectrum* B-mode image 
О Doppler spectrum 
• massage 
Figure 2 Time schedule of the study protocol 
Duplex ultrasonographic grading of the erectile response 
We used the difference between resistance indices in phases 2c and 1 to grade 
erectile response: theoretically, diastolic flow velocity resets at its phase 1 value ( i.e. 
0 in 83/88 (94%) of the measured cavernous arteries) and hence resistance index at 
1.00 as soon as the intracavemous pressure equals or exceeds systemic diastolic 
blood pressure. This fact combined with the knowledge that the intracavemous 
pressure of a full erection exceeds systemic diastolic pressure, leads to the 
conclusion that RIphase2c equals or exceeds RIphasel in a state of full erection. 
Hence, the volunteers were classified into 2 groups: (Group A) — RIphase2c >. 
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RIphasel or positive erectile response, (Group B) - RIphase2c < RIphasel or 
negative erectile response. 
Statistical analysis 
In previous studies it has been demonstrated that the reproducibility of 
measurement of blood flow velocity and acceleration time is disappointing, due to 
variables associated with the process of obtaining the tracings.[7] To filter out these 
variables as much as possible, in this study the phase 2a values for the Doppler 
parameters were averaged to describe their early post-injection value. RI is much 
less dependent on variables associated with the process of measuring, therefore its 
minute to minute values in phase 2a were used to monitor the alternations of blood 
flow. The reference values for acceleration time, peak flow velocity, diastolic flow 
velocity and resistance index for phase 2a were obtained by distribution-free 
estimation of the 5th (P05) or, where appropriate (acceleration time) the 95th 
(P95) percentile of their population distribution. Statistical comparison between 
groups A and В for acceleration time, peak flow velocity, diastolic flow velocity and 
resistance index simultaneously over the different phases of erection was done by 
means of the Koziol test. 
Results 
Figure 3 depicts characteristic Doppler spectra in different phases of erection. 
Deflection of the spectrum above the baseline indicates antegrade flow towards the 
probe. The x-axis indicates time, the y-axis frequency shift or flow velocity (cm/sec). 
None of the parameters appeared to be age-related. 
Phase 1 
A typical phase 1 Doppler spectrum consisting of systolic flow with retrograde 
diastolic flow was recorded in 83 out of 88 of the measured arteries (94%). This 
type of spectrum indicates high cavernous resistance (RI=1.00). In 5 (6%) 
cavernous arteries a pattern consisting of systolic and antegrade diastolic flow was 
measured. This type of spectrum indicates the occurrence of collaterals of the 
cavernous arteries to a low resistance vascular bed (outside the cavernous body) 
(RI<1.00). 
Phase 2a 
The first Doppler spectrum could be recorded within one minute after injection in 
31 (70%) of the volunteers. Within the first two minutes we succeeded in obtaining 
a Doppler spectrum in all subjects. The typical phase 2a Doppler spectrum was 
characterized by an increase of acceleration time (from 53 ms in phase 1 to 73ms in 
phase 2a), peak flow velocity (from 20 cm/s in phase 1 to 44 cm/s in phase 2a), 
diastolic flow velocity ( from 1 cm/s in phase 1 to 12 cm/s in phase 2a) and a sharp 
decrease of RI (from 0.98 in phase 1 to 0.71 in phase 2a) (Table 1 - 4). 
Phase 2b 
In phase 2b acceleration time and peak flow velocity stabilized (Table 1 and 2). 
Diastolic flow velocity decreased from 12 to 9 cm/s and so RI increased from 0.71 
to 0.77 (Table 3 and 4). Mean arterial diameter increased from 1.4 +. 0.2 mm to 1.7 
+ 0.2 mm (dilatation: 21%). 
Phase 2c 
In phase 2c acceleration time, diastolic flow velocity and RI approximated their 
phase 1 values. In contrast to the other Doppler parameters, peak flow velocity was 
steady throughout the post injection phase (44, 43 and 41 cm/s) (Table 1 - 4). 
Reference values for acceleration time, peak flow velocity, diastolic flow velocity and 
resistance index are given in table 5. 
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Figure 3 Doppler spectra in different phases of erection 
(a) Phase 1 Waveform consisting of systolic blood flow and retrograde diastolic blood 
flow. The retrograde diastolic flow indicates high cavernous resistance; (b) Phase 2a A 
continuous waveform consisting of systolic and antegrade diastolic flow, (c) Phase 2b 
Steady peak flow velocity. Diastolic flow velocity has decreased; (d) Phase 2c Full 
erection. Intracavemous pressure exceeds systemic diastolic pressure, causing diastolic 
flow to equal zero (RI = 1.00) 
50 Chapter 4 
TabU I Acceleration lime (ms) in groups A and В in different phases of erection 
All volunteers (M«44) 
Acceleration 
Time MEAN SD HIN HAK 
Phase 1 S3 18 20 100 
Phase 2a 73 24 34 155 
Phase 2b 70 25 32 136 
Phase 2c 57 23 24 112 
Group A (N<31) 
MEAN SO HIK HAX 
54 16 28 100 
70 20 34 146 
64 24 32 136 
53 20 24 96 
Group В <H»13) 
K02IOL 
HEAN SO HIN HAX -test 
p-value 
53 23 20 96 
78 31 48 155 
82 25 56 136 
66 27 24 112 
0.01 
•significant contrast 
Table 2 Peak flow velocity (cm/s) in groups A and В in different phases of erection 
All volunteers (N=44) 
Peek Ho* 
velocity WAN SO HIN HAX 
Phase 1 20 11 7 69 
Phase 2a 44 19 19 120 
Phase 2b 43 21 8 121 
Phase 2c 41 22 14 105 
Сгснф A (N=31) 
HEAN SD HIN HAX 
21 9 7 43 
42 16 19 86 
45 23 14 121 
39 24 14 105 
Group В (N=13) 
K0ZIOL 
HEAN SO HIN HAX -test 
p-value 
20 15 10 69 
49 24 22 120 
38 16 В 64 
43 15 24 66 
0 67 
•significant contrast 
Table 3 Diastolic ßow velocity (tm/\) in groups A and В in different pha\es of erection 
Diastol 1С 
flow 
velocity 
Phase 1 
Phase 2a 
Phase 2b 
Phase 2c 
All 
HEAN 
1 
12 
9 
3 
volint 
SO 
2 
6 
S 
5 
eers (N= 
HIN 
0 
5 
2 
0 
14) 
HAK 
10 
30 
26 
17 
HEAN 
1 
11 
» 1 
Group A 
SO 
2 
5 
6 
3 
(N=31) 
HIN 
0 
5 
2 
0 
HAK 
10 
27 
26 
17 
HEAN 
0 
15 
10 
9 
Group В 
SO 
0 
6 
5 
4 
(N=13) 
HIN 
0 
7 
4 
3 
HAX 
0 
30 
19 
17 
KOZIOL 
test 
ρ value 
0.01 
•significant contrast 
Table 4 Resistance index in groups A and В in different phases of erection 
All volinteers (N=44) 
Resistance 
inden HEAN SO HIN HAX 
Phase 1 0.98 0 07 0.68 1.00 
Phase 2a 0.71 0.07 0.52 0.85 
Phase 2b 0.77 0.09 0.50 0.91 
Phase 2c 0.92 0.12 0.55 1.00 
Group A (N=31) 
HEAN SD HIN HAX 
0.97 0 08 0 68 1.00 
0.73 0 06 0.60 0 85 
0 79 0.07 0 60 0.91 
0.99 0 05 0.80 1.00 
Group В (N=13) 
KOZIOL 
HEAN SO HIN HAX -test 
ρ value 
1.00 0.00 1.00 1.0O 
0 68 0.09 0.52 0.77 
0.73 0.10 0.50 0.86 
0.78 0.09 0.55 0.89 
not done 
•significant contrast 
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Erectile response 
Thirty-one (70%) volunteers had a full erectile response according to the criterion 
RIphase2c >. RIphasel (Group A). In 28 (90%) of these men this finding correlated 
with the clinical finding of a full erection. In 13 (30%) men RIphase2c did remain 
below its phase 1 value (Group B). In 12 (92%) of these men this finding 
correlated with the clinical finding of absence of full erection. 
Statistical comparison of groups A and В 
In tables 1 - 4 the mean, standard deviation, minimum and maximal values for 
acceleration time, peak flow velocity, diastolic flow velocity and resistance index in 4 
phases of erection for all volunteers and separately for groups A and В are given. 
Statistical significant differences between groups A and В were found for 
acceleration time and diastolic flow velocity. Both were higher in group В after 
injection and, in contrast to group A did not return to phase 1 value. 
Resistance index in different phases of erection 
Figure 4 depicts the minute to minute values of resistance index in groups A and B. 
Overall RI showed a sharp decrease without delay after injection (from a mean of 
0.98 in phase 1 to a mean of 0.71 in phase 2a). In 32 (73%) volunteers the lowest 
value for RI was noted at the first measurement after papaverine injection. After 
the initial fall, RI increased to a steady state in both groups. 
Table 5 Reference values for phase 2a 
Acceleration time ( P 9 5 ) 122 ms 
Peak flow velocity (P05) 22 cm/s 
Diastolic flow velocity (P05) 6 cm/s 
Resistance index: (P05) 0.79 
Discussion 
Theoretically, measurement of blood flow (volume per unit time) in the entire 
cavernous arterial system should be the best indicator of penile arterial capacity. 
However, in clinical practice measurement of the volume of blood flow is illusory. 
At our institution, penile duplex ultrasonography is used principally as initial 
screening test to evaluate cavernous blood flow. As a non-invasive technique it aids 
in selecting patients for penile angiography. Although color flow imaging improved 
visualization of the cavernous arterial system, selective pudendal angiography 
remains the gold standard to study the architecture of the penile arterial system.[8] 
In the literature the use of duplex ultrasonography as tool to assess penile blood 
flow is subject to much debate. Questions have been raised about reference values 
and the timing of measurement during penile erection.[7] Because we did not want 
to add to this confusion, we studied a group of men with normal erectile potency, 
and relied on data obtained in a strictly time-dependent manner following the 
administration of papaverine. 
Based on the data regarding penile hemodynamics published by Lue et al., we 
studied 4 phases of erection. Flaccid phase, initial filling phase, tumescence phase 
and rigidity phase.[5] Hemodynamically, two phases are most important: the initial 
filling phase (in this study phase 2a) to evaluate arterial inflow and the rigidity 
phase (in this study phase 2c) to study venous outflow. To date, peak flow velocity 
is the most common used ultrasonographic parameter of the cavernous inflow tract. 
We observed that peak flow velocity, in contrast to other duplex parameters is 
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steady throughout the post injection phase. This phenomenon is explained by the 
fact that peak flow velocity as a function of systemic systolic blood pressure is not 
influenced by intracavemous pressure as long as the systemic systolic pressure 
exceeds intracavemous pressure Given this fact and given the fact that the 
measurement of cavernous blood flow velocity is known to be strongly influenced by 
variables associated with the process of measuring, we averaged the early post-
injection values to increase diagnostic accuracy, instead of relying on one 
measurement.[9] With this approach we found an age-independent reference value 
(P05) of 22 cm/s 
Dilatation is used as parameter to assess the local condition of the cavernous 
artery Lue found that if the cavernous artery does not dilate by 75% there is a high 
likelihood of arterial disease [10] Other investigators found cut-off values of 119% 
and 100% [3, 11] We were not able to confirm these findings. We believe that 
arterial dilatation is an unreliable parameter for several reasons: Measurement of 
diameter depends on alignment of cursors to the vessel wall, introducing a subjective 
component Another reason is that the diameter of the cavernous artery is 
influenced by changing intracavemous pressure With increasing pressure, the artery 
is compressed, causing decrease in diameter Finally, positioning of the probe before 
and after injection may be different In order to ensure uniformity, we believe it is 
necessary to correlate arterial dilatation to the site (proximal - distal) of sampling 
and the phase of erection. 
Doppler studies of the femoral vascular bed have shown that acceleration time 
can be used to assess the inflow tract [12, 13] Recently, Melhnger studied blood flow 
acceleration to assess penile inflow, and found it to be more accurate than peak 
flow velocity [14] Acceleration is a function of peak flow velocity over acceleration 
time We used acceleration time alone, to avoid inaccuracy introduced by peak flow 
velocity. As shown in table 1 the value for acceleration time is correlated to the 
phase of erection: early post-injection phase is associated with prolongation of 
acceleration time. In the late post-injection phase acceleration time returns to its 
pre-injection value. Obviously, the value for acceleration time should be related to 
the phase of erection. We have seen that 95% of the volunteers have an 
acceleration time of less than 122 ms in the early post-injection phase It is 
important to note that even though examinations were performed by an experienced 
technician we found considerable variation between subsequent measurements, 
indicating the role of errors of sampling. As for peak flow velocity, we recommend 
averaging of the phase 2a values for acceleration time in order to enhance accuracy 
Animal studies have shown that intracavemous resistance and arterial flow are 
closely related.[5] In the flaccid state, the contracted helicme arteries provide high 
cavernous resistance resulting in minimal blood flow. Following intracavemous 
pharmacological stimulation, the helicine arteries open, causing an abrupt decrease 
of cavernous resistance and increase of arterial blood flow. As blood flow rate 
increases, the penis expands and intracavemous pressure rises to a steady state in 
full erection As intracavemous pressure rises, vascular resistance increases, resulting 
in a decrease of blood flow to a steady state. As soon as cavernous pressure and 
volume are steady, cavernous inflow equals venous outflow. 
Pourcelot introduced an index of vascular resistance derived from the Doppler 
spectrum. Resistance Index.[6] In the formula RI = (peak flow velocity - diastolic 
flow velocity) / (peak flow velocity) the probe-vessel angle is filtered out and hence 
the most important variable associated with the process of sampling. Therefore RI 
appears to be an outstanding parameter to monitor alternations of penile blood 
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flow. Figure 4 depicts the pattern of values for resistance index measured in men 
who were classified according to erectile response in two groups (groups A and B). 
The figure shows that RI reflects the pattern of cavernous blood flow in different 
phases of erection, as was described above: a high resistance pattern, indicating 
minimal blood flow is noted in the flaccid state. Within one minute after papaverine 
injection values for RI decrease dramatically to a minimum, indicating maximal 
inflow. Although the fall of RI at one minute post injection seems to be less 
pronounced in group B, we observed that the actual minimum value of RI occurs 10 
- 20 seconds after injection i.e. prior to the first measurement and probably is equal 
for both groups. The assumed sequence of RI during the first minute following 
injection is depicted by the dotted line in figure 4. 
resistance index 
f group A - — group В 
i 
1 2 3 4 5 θ 11 time (mm) 
papaverine 
miection phase 
1 2a 2b 2c 
Figure 4 Resistance index (RI) in groups A and В measured before and at one, two, 
three, four, five, between 5 and 8, and between Π and 15 minutes after papaverine 
stimulation (continuous line). The proposed course of RI within the first minute after 
papaverine injection is indicated by the dotted line. 
During the further course of the post injection phase, the value for RI adjusts to 
a level depending on intracavemous pressure: As soon as intracavemous pressure 
equals or exceeds diastolic pressure, diastolic flow will approximate zero and the 
value for RI equals 1.00. As long as intracavemous pressure remains below systemic 
diastolic pressure, diastolic flow will persist and the value for RI will remain below 
1.00. 
It has been estimated that an intracavemous pressure of 80-100 mmHg is 
necessary for full erection.[5] As a consequence, a post injection value of 1.00 
indicates full erection, whereas a post injection value < 1.00 indicates incomplete 
erection. However, we found that RI may remain below 1.00 despite full erection or 
may equal 1.00 without full erection. 
There may be several reasons for the difference between clinical and 
ultrasonographic grading of erection. One reason could be that the cavernous artery 
0 6 
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has collaterals to a low resistance vascular bed outside the cavernous body, resulting 
in persistent diastolic flow during full erection.[15] These arteries can be recognized 
by the finding of a pre-injection RI value below 1.00. To obviate such a false 
negative result, we use the difference between RIphase 1 and RIphase 2c rather 
than absolute values to grade erection. Another possibility may be poor accuracy of 
palpatory grading of erection Furthermore it is possible that the diastolic blood 
pressure in the cavernous artery is higher or lower than full erection pressure. 
Finally, it is also possible that intracavemous pressure may have been influenced by 
manipulation of the penis at the time of scanning 
In an effort to define the hemodynamic factors that predetermine a full erection, 
we compared duplex parameters in volunteers, who were classified according to 
erectile response. Comparison of both groups yielded no significant differences for 
parameters of the initial filling phase (acceleration time, peak- and diastolic flow 
velocity in phase 2a) (Table 1 - 3). In other words, the failure to develop a full 
erection could not be ascribed to a failure of arterial inflow as assessed by duplex 
ultrasonography. We therefore conclude that the failure to develop full erection is 
due to veno-occlusive failure. 
Veno-occlusive disease may occur when there is an anatomical or functional 
abnormality of the cavernous body resulting in inadequate mechanical occlusion of 
the emissary venules against the tunica albuginea.[16] Because structural and 
functional changes of the cavernous body are not likely in men with normal erectile 
potency, the failed erection can only be explained by anxiety and consequent high 
adrenergic-constnctor tone at the time of duplex scanning. The data show that 
erectile impotence associated with anxiety is caused by veno-occlusive rather then 
arterial dysfunction. 
In previous studies we found clinical and morphological support for the concept of 
presbyrectia, as described by Kaplan (i.e <т age-related decrease of erectile 
potency) [17-19] In this study we did not find a relation between hemodynamic 
parameters and age. This can be explained by the fact that we studied a group of 
selected men 
We have shown that accurate assessment of penile blood flow involves acquisition 
of Doppler spectra in all phases of erection following administration of a vaso-active 
agent. In our opinion the averaged peak flow velocity and acceleration time in the 
early post injection phase may be used to assess arterial inflow. Resistance index 
appeared to be a reliable parameter to monitor the alternations of blood flow. The 
formula: RIpre-injection - Rílate post-injection may be used to grade erectile 
response.The functional basis of anxiety-mediated erectile failure is veno-occlusive 
dysfunction. 
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Abstract 
Alternations of penile blood flow are thought to be the most frequent organic cause 
of erectile dysfunction. Intracavernous injection of vaso-active agents is an accepted 
method for diagnosis of penile vascular dysfunction. To determine the diagnostic 
efficacy of commonly used vaso-active drugs we studied the hemodynamic effects of 
different dosages of papaverine, the combination of papaverine/phentolamine and 
Prostaglandine El (PGEl) in men with erectile dysfunction and men with normal 
erectile potency using color duplex ultrasonography. 
It was concluded that, due to optimal hemodynamic effects and low risk of 
prolonged erection 12.5 mg papaverine and 10 μg PGEl are the drugs to be used in 
conjunction with penile duplex ultrasonography. 
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Introduction 
Alternations of fienile blood flow are thought to be the most frequent organic cause 
of erectile dysfunction (ED). Two pathological states can be distinguished: 
arteriogenic erectile dysfunction secondary to diminished cavernous arterial inflow 
and veno-occlusive erectile dysfunction secondary to inadequate mechanical occlusion 
of the emissary venules against the adjacent tunica albugínea.[1] 
Since the publication of Virag in the Lancet in 1982, intracavemous injection of 
vaso-active agents is an accepted method for diagnosis and treatment of penile 
erectile dysfunction.[2] Commonly, three different agents are used: papaverine, the 
combination of papaverine/phentolamine, and Prostaglandine E l (PGE1). These 
substances substitute for the neurotransmitter to test the arterial, venous and 
sinusoidal mechanisms and to differentiate vascular from psychogenic and 
neurogenic erectile dysfunction.[3] A positive test, defined by a rigid erection implies 
a normal vascular status. If only partial, shortlived, or no erection results, than 
hemodynamic impairment may be suspected. 
Although the pharmacotest has found a widespread application, at present there is 
no standardized pharmacological agent, dose, or method of monitoring the 
hemodynamic response in this test. Commonly, the pharmacologic effect is rated by 
the palpatoir assessment of penile rigidity, resulting in a positive or negative 
response.[4] This dichotomous classification has the problem, that it does not allow 
for grading of vascular impairment nor distinction can be made between 
insufficiency of inflow and veno-occlusive dysfunction. With the advent of black and 
white and later color duplex ultrasonography, a more subtle assessment of the 
arterial response and veno-occlusive function became possible.[5-8] 
To determine diagnostic efficacy of the various vaso-active agents we studied the 
hemodynamic effects of different dosages of papaverine, the combination of 
papaverine/phentolamine and PGE1 in men with erectile dysfunction and men with 
normal erectile potency using color duplex ultrasonography. 
Patients and methods 
Patients 
Duplex ultrasonography before and following pharmacological stimulation was 
performed in 280 consecutive patients with ED (mean age ±_ sa, 53 + 12 years) 
and 44 males with normal erectile potency (controls) (mean age _+ sd, 56 ± 11 
years). All patients had difficulty in obtaining and/or maintaining erection. Of all 
participants a detailed medical history was obtained including the identification of 
vascular risk factors. The following factors were considered to be vascular risk 
factors: hypertension, hyperlipidemia, smoking, diabetes mellitus, coronary heart 
disease, cerebral and peripheral vascular disease, history of vascular surgery, history 
of pelvic trauma, surgery or radiation therapy. 
Methods 
The patients were assigned to one of five groups. In each group a different dosage 
or a different agent was used for intracavemous stimulation at the time of duplex 
ultrasonography (Table 1). The controls were injected with papaverine 12.5 mg. All 
examinations were performed by the same investigator and technician. The male was 
supine and the penis with the dorsum exposed. A commercially available duplex-
scanner with color flow imaging possibilities was used. B-mode color images and 
Doppler spectra were obtained with a 5 MHz linear-array transducer. B-mode 
ultrasonography provided visualization of the diameter of the cavernous arteries in 
the proximal penile shaft and an axial resolution of 0.1 mm could be obtained. 
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Color imaging was then performed to display blood flow in the cavernous arteries. 
By using the color image as a guide to the location and direction of flowing blood, 
the Doppler sample volume cursor (sample volume = 1 mm) was placed accurately 
in the cavernous artery as proximal as possible in the infrapubic region, and the 
Doppler angle correction cursor was adjusted to match the correct axis of flow. The 
resulting angle-corrected Doppler spectrum was displayed on the monitor, and 
acceleration time, peak flow velocity, and end-diastolic flow velocity were measured 
directly from the recorded velocity tracing. [3, 9] That information was used to 
calculate resistance index (RI).[10] 
Table 1 Agents, dosages and volumes used in this study 
Group 
1 
2 
3 
4 
5 
η 
70 
56 
91 
25 
38 
agent 
papaverine 
papaverine 
papaverine 
papaverine/phentolamine 
Prostaglandine 
dosage 
mg (ßg) 
12.5 
25 
50 
15/0.5 
10 (μ 8 ) 
volume 
(ml) 
0.25 
0.5 
1.0 
1.0 
0.2 
Study protocol 
To assess the alternations of cavernous blood flow in different phases of erection, 
the study protocol was designed to perform duplex ultrasonography in a time-
dependent manner following intracavernous injection. Three phases were defined: 
Phase 1, before injection; Phase 2a, first 5 minutes following injection, and Phase 2, 
between 7 and 12 minutes following injection. 
Phase 1 
Before injection the diameter and the Doppler spectrum of both cavernous arteries 
were obtained. Because arterial diameters and the Doppler spectra were very alike 
for the left and right side, the left-right averaged data were used to describe this 
phase. 
Phase 2a 
In the first 5 minutes following injection, Doppler spectra of the cavernous artery 
with the strongest response were sampled at one minute intervals. The average of 
the values for acceleration time and peak flow velocity and the minimum RI was 
used to describe phase 2a. 
Phase 2b 
Between 7 and 12 minutes after injection the diameters of both cavernous arteries 
were measured and a Doppler spectrum was obtained. Dilatation of the cavernous 
artery was calculated by the formula: 
Hiame.ter following injection - diameter before injection mnw 
diameter before injection 
In order to study the surplus erectile effect of manual stimulation and privacy, in 
the volunteers a Doppler spectrum was obtained between 11 and 15 minutes after 
injection after they had been asked to massage the penis and after the investigators 
had left the room for 3 minutes. 
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Prolonged erection 
All participants were ask to contact the investigator in case they would develop a 
erection lasting more than 6 hours post-injection.[11] 
Statistical analysL· 
Data concerning pharmaco-duplexscanning were recorded on a specially designed 
data entry form. The mean value and its standard error for acceleration time, peak 
flow velocity, diastolic flow velocity, resistance index and dilatation of the cavernous 
artery in phases 1, 2a and 2b in groups 1, 2, 3, 4, 5 and controls were calculated. 
(Table 2) To assess the interaction between dose-effects and phase-level, a statistical 
comparison between groups, that were injected with different dosages of papaverine 
(groups 1 and 2 and 3), between groups that were injected with 12.5 mg papaverine 
and the combination of papaverine/phentolamine (groups 1 and 4), between groups 
that were injected with 50 mg papaverine and 10 μg PGE1 (groups 3 and 5) and 
patients that were injected with 12.5 mg papaverine (group 1) and controls was 
done by means of two-way (group X phase) analysis of variance (Table 3). 
Table 2 Duplex parameten before and after intracavemous injection of different 
pharmacological agents in different dosages in patients and controls 
Agent 
Dosage 
N 
Acceleration time (ms) 
phase 1 
phase 2a 
phase 2b 
Peak flow velocity Ccm/s) 
phase 1 
phase 2a 
phase 2b 
Diastolic flow velocity (cin/s) 
phase 1 
phase 2a 
phase 2b 
Resistance Index 
phase 1 
phase 2a 
phase 2b 
Dilatation of the 
cavernous artery (Z) 
PATIEKTS 
PAPAVERINE PAP/PHEN PGE1 
12.5 mg 25 mg 50 mg 15/0.5 mg 10 ид 
70 56 91 25 3β 
63 + 3* 5 7 + 2 6 2 + 2 5 8 + 5 6 7 + 3 
76 + 3 70 + 2 83 + 3 69 + 3 80 + 3 
7Д + 3 68 + 3 8 6 + 3 7 1 + 4 77 + 3 
1 8 + 1 22 + 2 24 + 2 17 + 2 15 + 1 
40 + 2 43 + 3 50 + 3 36 + 3 3 7 + 2 
36 + 3 37 » 3 45 + 3 29 + 3 38 + 3 
1+0.2 1+0.2 2 + 0 3 1+0.4 1+0.3 
12+0.6 13+1.0 17+1.2 12+0.9 11+0.9 
8 + 0.6 8 + 0.6 11 + 1.1 5 » 0.6 β + 1.0 
.96 * .01 .97 • .01 .93 + .01 .96 · .02 .94 » .02 
.62 + .01 .60 » .01 .60 · .01 .59 i .02 .62 • .01 
.77 • .01 .76 « .02 .73 · .02 .80 • .02 .76 • 03 
2 6 + 2 3 1 + 3 32 + 2 37 ί 5 27 + 3 
CONTROLS 
PAP 
12.5 mg 
44 
53 · 3 
73 • 4 
69 * 4 
20 + 2 
44 + 3 
41 + 3 
1 + 0.3 
12 · 0.9 
9 + 0.9 
.98 · .01 
.66 • .01 
.79 » .02 
25 · 2 
* Me;m ± Standard Error of Ihe Mean 
Results 
The incidence of vascular risk-factors in the patient groups and controls was very 
much alike (range from 43% to 28%). Based on previous experience with black and 
white penile duplex ultrasonography in more than 100 patients we succeeded to 
obtain Doppler spectra according to a time-dependent measurement protocol in all 
investigations. It should be noted that following injection, the artery with the 
strongest response was chosen for sampling because accurate scanning of both 
arteries at 1 minute intervals appeared to be impracticable. The validity of unilateral 
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sampling was supported by the fact that comparison of the bilaterally obtained 
phase 1 Doppler spectra showed no significant differences. 
In table 2, the mean +. standard error of the mean for acceleration time, peak 
flow velocity, diastolic flow velocity, resistance index and dilatation of the cavernous 
artery are given for the different groups in 3 phases of erection. The measured 
values show a specific pattern in the 3 phases of erection for all groups: following 
injection (phase 2a), a distinct increase is noted for acceleration time, peak flow 
velocity and diastolic flow velocity. Consequently for RI a sharp decrease is 
observed. In phase 2b the parameters tend to adjust towards their pre-injection 
values. This course is most pronounced for diastolic flow velocity and resistance 
index. Resistance index measured in the controls after penile massage was 0.92. 
Table 3 Comparison * of hemodynamic effects of papaverine in different dosages in 
patients and volunteers, the combination of papaverine Iphentolamine and Prostaglandine 
El 
p-velue 
Acceleration time 
Peek floH velocity 
Diastolic flou velocity 
Resistance index 
Di latat ion of the 
cavernous artery 
Pap. 
3-dosages 
Groups 
.09 
. M 
.12 
.53 
.18 
1/2/3 
Pap./ 
Coi*. 
Groups 
.84 
.37 
.16 
.18 
.03 
1 Λ 
Pap./ 
PGE1 
Groups 3 / 5 
.10 
.58 
.и 
.67 
.18 
Pts/ 
Controls 
Сгоіф 1/ 
Controls 
.56 
.89 
.59 
.76 
.90 
* Two-way (group X phase) analysis of variance: 
Test for interaction between group differences and phase-level 
Comparison of the phase 1 values for patients and controls yields no significant 
differences except for acceleration time, that is higher in patients (p=0.02). 
Comparison of the hemodynamic effects of different drugs and different dosages of 
papaverine shows no significant difference in course between drugs (dosages) and 
phase-levels (Table 3, p-values homogenously varying between 0 and 1 as can be 
expected under null hypothesis of no-interaction). The rate of prolonged erections is 
listed in table 4. 
Table 4 Rate of prolonged erections ( > 6 hours) 
Agent 
Papaverine 
Papaverine 
Papaverine 
Papaverine/phentolamine 
PGE1 
dosage 
mg (ßg) 
12.5 
25 
50 
15/0.5 
(10) 
0.9 
5.3 
8.7 
4.0 
0.0 
Penile phannaoo-dupta-oltrasonograpliy 63 
Discussion 
The ideal agent for pharmacological erection testing would be one that would cause 
full erection in all men with a normal cavernous vascular function without inducing 
prolonged erection. Comprehensive diagnostic tests would then be preserved for 
non-responders to differentiate between insufficiency of arterial inflow and veno-
occlusive dysfunction. Unfortunately, to date the ideal drug is not available nor have 
been defined the clinical criteria for erectile response. Furthermore, the failure to 
produce an erection may be due to psychological factors in some patients whereas 
in others a positive erectile response may occur despite arterial and/or veno-
occlusive dysfunction. 
In the literature, PGE1 has emerged as the most promising diagnostic drug, with 
an overall erection rate of 74% and a prolonged erection rate of only 0.1%.[12] 
Depending on dosage, for papaverine/phentolamine a prolonged erection rate of 
5.3%, and for papaverine mono-substance a rate of 9.5% is quoted.[13] In our series 
consisting of controls and unselected patients we found that papaverine in a dosage 
of 12.5 mg and PGE1 in a dosage of 10 Mg are the safest agents in preventing 
prolonged erection. However, are PGE1 and low dose papaverine as effective as the 
other drugs and dosages to activate arterial and veno-occlusive responses? 
Penile duplex ultrasonography is a subtle method to monitor cavernous 
hemodynamic responses to pharmacological stimulation. A study, comparing the 
diagnostic value of penile angiography (to date the standard method to diagnose 
arteriogenic impotence) and duplexscanning revealed a good correlation between the 
two methods.[14] Recently, the use of duplex ultrasonography as a means of 
diagnosing veno-occlusive dysfunction is gaining acceptance in the literature.[15] 
Theoretically, ultrasonographic assessment of arterial and veno-occlusive responses 
is achieved in different phases of erection using different Doppler parameters. 
Inflow response in the phase of highest flow rates, starting immediately following 
intracavernous injection (in this study: phase 2a), using peak flow velocity, 
acceleration time and dilatation of the cavernous artery. Veno-occlusive response in 
phases when arterial inflow equals venous outflow, i.e. when cavernous pressure and 
volume are steady (in this study: phase 2b), using resistance index as the parameter 
of venous resistance. The higher RI, the higher venous resistance. In a state of full 
erection RI equals 1.00. 
As demonstrated in tables 2 and 3 no differences were found for the effects of 
the different dosages of papaverine nor the different agents in the phase of arterial 
response (phase 2a). Apparently, the lowest dosage used sufficed to induce maximal 
relaxation of the smooth-muscles coating the cavernous and helicine arteries. This 
Finding suggests that increase of post-injection cavernous blood flow rate does not 
depend on dosages nor agents used in this study. In contrast, the higher incidence of 
prolonged erection in patients receiving higher dosages of papaverine or the 
combination of papaverine/phentolamine indicates a dose related response of the 
trabecular smooth-muscles lining the sinusoids that mediate veno-occlusion. 
Surprisingly, no differences were found between the arterial response in patients 
and controls. This finding supports the impression that most men with vasculogenic 
erectile dysfunction predominantly have veno-occlusive dysfunction rather than 
significant arterial insufficiency of the penile inflow tract. Probably, atherosclerotic 
disease primarily leads to structural alternations of the cavernous body and 
subsequently to veno-occlusive dysfunction.[16] In this concept, significant 
impairment of arterial inflow is not encountered until a late stage of atherosclerosis. 
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This finding questions the high rate of vascular reconstructive surgery performed by 
some authors.[17, 18] 
Several authors have pointed out that cavernous veno-occlusive dysfunction may 
occur in anxious patients with excessive adrenergic-constnctor tone.[19, 20] The data 
we obtained in controls corroborate these findings and emphasize the inhibiting 
effect of the test setting on the value of pharmacological testing of veno-occlusive 
function. We noted a mean RI in phase 2b of 0.79, whereas in full erection 
(adequate veno-occlusion) a RI of 1.00 is expected. Therefore the effect of 
additional manual stimulation and privacy on erectile response was tested. RI 
increased from 0.79 to 0 92, but still only 31/44 (70%) controls had a full erectile 
response after massage It should be notified that another 9 (20%) controls 
developed a full erection after they had left the vascular laboratory. Similar effects 
were observed in patients. 
Our impression on basis of these data is that even if psychological inhibiting 
factors are diminished as much as possible, veno-occlusion may be insufficient due 
to adverse psychological factors, irrespective the pharmacological agent or dosage 
used. Therefore, the value of pharmacological testing of veno-occlusive function in a 
clinical setting is limited Moreover the results of studies that compare the diagnostic 
value of cavemosometry and penile duplex ultrasonography must be interpreted 
carefully [15] Theoretically, cavemosometry as well as duplex ultrasonography can be 
applied to assess venous outflow resistance. However, validation of duplex 
ultrasonography by comparison with cavemosometry is dubious because both 
methods have a different invasiveness and anxiety content influencing veno-occlusive 
function. Furthermore, time after injection is a key-vanable in the interpretation of 
veno-occlusive findings obtained during duplex ultrasonography. In general, when 
interpreting tests for veno-occlusive function one should realize that both techniques 
have an intrinsic rate of false positive results 
In our experience, increase of pharmacological dosage and the use of a mixture of 
agents did not increase erection rate at the time of scanning, whereas the rate of 
prolonged erections increased Prolongation of observation period and addition of 
manual and/or visual stimulation will improve the accuracy of the method. However, 
patients' self-report on erectile response following duplex ultrasonography represents 
the most versatile test for "veno-occlusive function 
The authors conclude that 12 5 mg papaverine and 10 μg PGE1 are the drugs of 
choice to be used in conjunction with penile duplex ultrasonography due to optimal 
hemodynamic effects and low risk of prolonged erection 
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Abstract 
We performed cavernosometry in 96 patients with erectile dysfunction. Two different 
techniques were compared: pump-cavernosometry, utilizing a rollerpump as inflow 
source and gravity-cavernosometry, using an infusion set as inflow source. 
We conclude that the diagnostic value of both techniques is comparable. In pump-
cavernosometry, maintenance flow is the most accurate parameter of veno-occlusive 
function. Gravity-cavernosometry has the advantage of simplicity, cost-effectiveness 
and has a lower complication rate. Incomplete cavernous smooth-muscle relaxation 
appeared to be limiting the diagnostic value of both techniques. 
Gravity- and pump-averDOSometry in the evaluation of the тепо-оссІіБі е medunism 69 
Introduction 
Penile erection is a hemodynamic event under autonomic neurologic control, 
mediated by changes of the cavernous smooth-muscle tone. Disturbance of this 
process may result in dysfunction of the veno-occlusive mechanism.[l] The functional 
integrity of the veno-occlusive mechanism may be tested by intracavemous injection 
of a vasoactive agent. Veno-occlusive dysfunction is ruled out by a positive erectile 
response.[2] A negative response is indicative for impairment of the veno-occlusive 
mechanism.[3] 
Since Newman in 1964 introduced cavemosometry to study the veno-occlusive 
mechanism, different parameters have been described.[4] To date, it is generally 
accepted that cavemosometry should be performed following complete relaxation of 
the cavernous smooth-muscle, because venous outflow resistance is modulated by the 
tonus of the cavernous smooth-muscles: relaxation results in elevation of venous 
outflow resistance.[ 1] In cavemosometry, venous outflow resistance is assessed by 
determining the relationship between intracavernous flow rate of saline required to 
create or sustain an erection or by infusing saline and determining the rate of the 
fall in pressure after the infusion is stopped. Infusion rate is regulated by a 
roIlerpump.[5] 
In 1988, Puech-Leao introduced a modified technique. Instead of a pump he 
employed an infusion set to control the infusion rate (gravity-cavemosometry). In 
gravity-cavernosometry, intracavernous pressure tends to equal the pressure of the 
source. The more intracavernous pressure equals infusion pressure, the better the 
status of the veno-occlusive mechanism.[6] Gravity-cavernosometry seems to be an 
asset in the existing diagnostic armamentarium because it is simpler and more 
economical than pump-cavernosometry, and therefore may be used more readily as 
an office test.[7] 
With the aim to determine the diagnostic significance of gravity-cavemosometry, 
we compared the veno-occlusive findings in patients undergoing both gravity- and 
pump-cavernosometry. 
Materials and Methods 
Patient population 
Pump-cavernosometry was performed in 96 patients with an average age of 54 years 
(range 25 - 77 years). Combined pump- and gravity-cavernosometry was performed 
in 48 patients. All patients had difficulty in obtaining and/or maintaining erection 
and their histories revealed factors associated with artenogenic and/or veno-occlusive 
erectile dysfunction. Table 1 depicts the prevalence of factors regarded to be 
associated with vasculogemc ED encountered in our patients. Drugs considered to 
be associated with vasculogemc ED were: antihypertensive, neuroleptic, psychotropic, 
anti-epileptic and broncho-dilatator drugs and corticosteroids.^] Patients with 
psychogenic or neurogenic ED were excluded from the study. 
Classification of patients 
On first consultation all patients underwent a pharmacotest in the office with an 
intracavernous injection of 50 mg of papaverine. A positive response was noted if 
rigidity was adequate within 10 minutes after injection. If the response was negative 
the test was repeated with the same dose of papaverine at a later date. According 
to the outcome of the first and/or second papaverine-test, patients were categorized 
into two groups: Group A: positive test. Group B: consistent negative test. In all 
patients cavemosometry was performed. Thus, group A: cavemosometry at a 
positive response and group B: cavemosometry at a negative response. Because they 
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Table 1 Prevalence (%) of factors associated with vasculogenic ED (n=96) 
Prevalence 
(X) 
70 
17 
8 
5 
3 
2 
2 
1 
1 
Factor 
Use of drugs 
Hypertension 
Previous pelvic surgery 
Angina pectoris 
Previous hypospadias repair 
History of pelvic/genital trauna 
Previous penile prosthesis 
History of priapism 
Prevalence 
(X) 
40 
IS 
β 
4 
2 
2 
1 
1 
Snaking 
Diabetes mellitus 
Peyronie's dieease 
Myocardial infarction 
Cerebro Vase. Accident 
Penile venous surgery 
Arterial insufficiency 
Chronic renal failure 
Renal transplantation 
had proven to be able to obtain a full erection, the patients of group A were 
considered to have a normal veno-occlusive mechanism.[2] Patients of group В were 
considered to have a high likelihood of veno-occlusive dysfunction.[3] 
Technique of cavernosometry 
Cavernosometry was performed on a fluoroscopy table under equal conditions by 
the same investigator, who made every effort to minimize inhibiting factors by 
creating an atmosphere of privacy, e.g. by limiting the number of personnel in the 
room and using infusion fluids at body temperature. At the start of cavernosometry 
a 19 gauge butterfly needle was inserted into the cavernous body at the base of the 
penis and 50 mg papaverine were injected. The needle was connected to a pressure 
monitor and correct placement was confirmed by observation of the typical pressure 
spikes provoked by squeezing of the penis or straining of the patient. 
Perfusion protocol and definition of the study parameters 
The set-up of combined gravity- and pump-cavernosometry is illustrated in figure 1. 
_£&_ 
η ι i n 
U IL 
mmHg 
pressure 
monitor 4 
Neofly19GN 
(0\ 1 mm) ι 
1 
/52^=—=- — ^-^sS 
Il ,£ave mous iL 
J 
^SNeofly 19 G 
Un.lmm) 
160cm 
120mmHg 
roller pump 
3-way 
stopcock 
body 
Figure 1 Set-up of combined gravity- and pump-cavemosometiy 
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Gravity-cavemosometry 
Succeeding the intracavemous injection of papaverine, steady state intracavernous 
pressure (ICP) was awaited. Then, a second needle was inserted at the contralateral 
side of the base of the penis and connected to a column of 160 cm of heparinized 
normal saline (equal to 120 mmHg). Free flow delivery was checked by a 
droplet-counting chamber that was incorporated in the system. The steady state 
intracavernous pressure (ICPg) was used as parameter of gravity-cavemosometry.[6] 
The infusion set was placed at 160 cm above the patient to generate an infusion 
pressure that is well above the commonly accepted erection pressure. 
Pump-cavemosometry 
After completion of gravity-cavernosometry, the infusion line was connected to the 
rollerpump, by turning the 3-way stopcock. The infusion protocol is depicted in 
figure 2. Three parameters were used for the interpretation of pump-
cavernosometry; pressure volume response (PVR), maintenance flow (MF) and 
pressure loss (PL).[9, 10, 5] 
PVR Saline infusion was started at a rate of 60 ml/minute. If intracavernous 
pressure did not reach 75 mmHg after one minute, infusion was stopped and steady 
state was awaited. Then perfusion was restarted at a rate of 120 ml/minute. Infusion 
was stopped as soon as cavernous pressure had reached 200 mmHg. PVR was 
computed by the formula: PVR = ICP/ volume(infused).[9] 
MF This phase of cavernosometry involved the recording of the flow required to 
maintain intracavernous pressure at 150 mmHg. A suprasystolic pressure was 
selected because at that pressure the external flow is isolated without any 
component of cavernous arterial inflow.[10] 
PL After ICP had set at a steady state equilibrium of 150 mmHg, infusion was 
stopped and pressure loss over a period of 30 seconds was determined.[5] 
Event 
Pump f lew 0 
(ml/mm) 30 
60 
90 
50mg lOmm 
papaverina stari stop 
gravity cavernosometry 
3 ^ 
Figure 2 The perfusion protocol of combined gravity- and pump-cavemosometry 
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Statistical analysa 
Data concerning history, pharmacotests, as well as cavemosometry were recorded on 
a specially designed data entry form and were analyzed with a computer. The 
distributional statistics of the values for each cavemosometry parameter were 
calculated and a statistical comparison between groups A and В was done by means 
of the Wilcoxon two-sample test. Reference values for cavemosometry parameters 
were obtained by calculation of the distribution free estimate of the 5th (P05) or, 
where appropriate the 95th (P95) percentile of the distribution for the parameters 
in group A. 
Theoretically, the diagnostic value of gravity- and pump-cavernosometry is equal if 
both techniques have the same ability to discriminate between the reference group 
and patients and the ranking of veno-occlusive findings is analogous in both 
techniques. Translated into statistical concepts in this study: 
1) The "distance" between groups A and В for the univariate distributions of the 
parameter of gravity-cavernosometry (ICPg) should be similar to the "distance" 
between the multivariate distributions of the parameters of pump-cavernosometry 
(PVR, MF and PL). In this study, the "distance" between the two distributions was 
described by the Mahalanobis distance, after square-root transformation for each of 
the 4 parameters.[ll] 
2) The parameter obtained by gravity-cavernosometry (ICPg) should correlate with 
the combined parameters obtained by pump-cavernosometry (PVR, MF, PL). The 
correlation between ICPg and (PVR, MF, PL) was assessed by standard multiple 
regression analysis, after square-root transformation for each of the parameters. The 
regression value for ICPg, noted as ICPg was calculated from the three pump 
variables and compared with the actual measured ICPg in groups A and B. As is 
usual, the square root transformation was used to achieve a better approximation to 
the multivariate normal distribution of ICPg, PVR, MF and PL. 
Results 
Papaverine-test 
On basis of 2 tests the response to 50 mg papaverine was positive in 52 patients 
(54%). Twelve (13%) patients, with an initial negative response, showed a positive 
response when tested again with the same dose (Figure 3). 
positive-« first papaverine test (50 mg) •negative 
η = 40 (η = 96) ^ n = 5 6 
positive ч second papaverine test (50 mg) -*• negative 
η = 12 (η = 56) η = 44 
Total positive = 52 Total negative = 44 
Figure 3 Classification of patients according to the results of the first and second 
papaverine test 
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Table 2 ICPg, PVR, MF, and PL in 48 patients in whom gravity- and pump-
cavemosometry was performed 
Patient ICPg PVR MF PL 
(mmHg) (mmHg/ml) (ml/min) (mmHg/sec) 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
115 
111 
80 
110 
110 
95 
100 
110 
106 
115 
85 
80 
107 
85 
80 
105 
80 
120 
35 
105 
100 
95 
5 
80 
60 
73 
10 
60 
100 
16 
10 
80 
100 
20 
30 
50 
5 
85 
87 
90 
95 
108 
95 
25 
95 
54 
85 
25 
23 3 
300 
83 
116 
112 
97 
14 1 
36 3 
137 
36 6 
67 
58 
100 
92 
70 
no 
1 1 
14 1 
80 
129 
15 
10 5 
4 0 
29 
0 0 
50 
95 
00 
00 
53 
33 
0 0 
15 
33 
10 
55 
13 
60 
125 
16 0 
124 
10 
12 9 
31 
61 
10 
3 
5 
15 
15 
20 
20 
8 
5 
30 
5 
5 
18 
10 
25 
1 
10 
25 
12 
25 
60 
25 
25 
35 
40 
15 
18 
100 
50 
200 
15 
50 
15 
5 
10 
11 
200 
25 
40 
17 
200 
13 
30 
30 
31 
31 
33 
23 
6 
4 0 
15 
13 
36 
18 
18 
10 
16 
25 
20 
3 3 
5 0 
31 
3 3 
30 
33 
36 
33 
15 
21 
4 0 
1 1 
13 
22 
15 
16 
2.0 
16 
5 0 
36 
4 0 
3 3 
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Cavemosometiy 
Complications were few and easily manageable. In 4 patients the infusion needle 
dislocated at the time of pump-cavernosometry. The procedure had to be stopped 
to prevent further extravasation. Interestingly, no dislocations occurred during the 
phase of gravity-cavernosometry. The maximal interval from injection to steady state 
intracavernous pressure was 16 minutes. In the majority of patients a steady state 
was reached within 10 minutes after injection. 
Table 2 lists the actual values of ICPg, PVR, MF and PL, measured in 48 subjects 
in whom both gravity- and pump-cavernosometry were performed. Incidently values 
are missing. 
In table 3 the distributional statistics and the comparison of results of 
cavernosometry in groups A and В are shown. No correlation was found between 
age and the cavernosometry parameters except for ICP (group A r = .30, group В 
r= .37). Significant differences (p<0 05) were found between groups A and В for all 
parameters. In 10 patients the threshold intracavernous pressvre for PVR (200 
mmHg) could not be reached: In 4 due to needle dislocation, in 3 due to severe 
pain and in 3 due to severe veno-occlusive dysfunction. Pain was noted especially in 
patients with Peyronie's disease and diabetes mellitus. In 4 patients MF could not 
be assessed because ICP did not reach 150 mmHg at maximal perfusion rate of 200 
ml/mm. 
Table 3 Dbtributional statvuics and comparison of groups A and В 
ICP 
(mmHg) 
ICPg 
(mmHg) 
PVR 
(mmHg/ml) 
MF 
(ml/mm) 
PL 
(mmHg/sec) 
group 
A 
В 
A 
В 
A 
В 
A 
В 
A 
В 
η 
52 
44 
22 
26 
45 
44 
46 
41 
48 
40 
mean ±_ s.d. 
29 + 19 
21 + 10 
97 + 19 
59 + 35 
9.2 + 8.4 
3.7 + 4.2 
14 + 13 
89 ± 8 2 
2.2 + 0.9 
3.3+ 1.3 
median 
25 
20 
102 
66 
6.1 
2.4 
10 
50 
2.2 
3.3 
range 
5 - 88 
6 - 50 
35 -120 
10 -108 
1.1 - 36.6 
0.0 - 16.0 
0 - 60 
5 -200 
0.5 - 4.0 
1.1 - 5.0 
p-valu 
.03 
<.001 
<.001 
<.001 
<.001 
•comparison between groups A-B 
Table 4 lists the reference values obtained in this study by calculating the 5th and 
where appropriate the 95th percentile in the reference group (A). In the same table 
reference values, drugs and dosages used in the literature are presented [5, 6, 9, 10, 
12-16] 
The Mahalanobis distance and discriminating ability between groups A and В for 
all parameters are listed in table 5. The greater the distance the better the 
separating potential of the parameter. It is clearly demonstrated that MF, followed 
by ICPg are the most accurate parameters to separate both groups. 
Finally, the conventional parameters obtained by pump-cavernosometry (MF, PVR 
and PL) were correlated to the parameter obtained by gravity-cavernosometry 
(ICPg). By multiple regression analysis we calculated the expected (regression) value 
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for ICPg, noted as ICPg and compared that value with the actually measured ICPg. 
The result is depicted in figure 4. It shows a good correlation (R= 0.52) between 
ICPg and ÍCPg. 
Table 4 Reference values of parameters of cavemosometry and the pharmacological 
agents used in the literature and in this study 
Parameter 
ICP 
(mmHg) 
ICPg 
(mmHg) 
PVR 
(mmHg/ml) 
MF 
(ml/min) 
PL 
(mmHg/sec) 
The literature 
(agent, dosage)[ref] 
>50 
(papaverine,60mg)[12] 
>80 
(papaverine,60mg)[13] 
mean systemic arterial pressure 
(papaverine,45mg, phentolamine : 
>110 
(papaverine, 100mg)[6] 
>1.0 
(papaverine,60mg)[9] 
<3 
(papaverine,45mg, phentolamine,2 
<5 
(papavei ine,60mg)[10] 
<7 
(papaverine,30mg, phentolamine,! 
<25 
(papaverine,50mg)[15] 
<25 
(PGE„30Mgr)[16] 
<1.5 
(papaverine,45mg, phentolamine,2 
J.5mg)[5] 
.5mg)[5] 
•0mg)[14] 
.5mg)[5] 
This study 
(papaverine, 
50mg) 
>10 
>42 
>1.7 
<48 
<3.8 
Table 5 Mahalanobb distance and discriminating ability between groups A and В for 
parameters of gravity- and pump-cavemosometry 
ICP 
ICPg 
PVR 
MF 
PL 
(PVR, MF, PL) 
Mahalanobis distance 
between groups A and В 
.05 
1.20 
1.03 
1.51 
.94 
2.13 
Discriminating ability* 
(percentage misclassificalion) 
Group A 
40 
5 
36 
7 
33 
10 
Group В 
45 
50 
30 
41 
38 
34 
* linear discriminant function technique 
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ICPg (mmHg) 
О 3 0 4 2 6 0 9 0 120 
ICPg (mmHg) 
* Group A (n-22) 0 Group В (n-26) 
Figure 4 Correlation between gravity- (ICPg) and pump-cavemosometry (ICPg) 
Discussion 
This study was performed in a patient population that was selected on basis of a 
history including vascular risk-factors. The high incidence of vascular factors is 
evidenced by the high percentage of patients with repeat negative papaverine-tests. 
Patients with a positive papaverine-test were appointed to serve as a control group 
for normal veno-occlusive function. The use of the papaverine-test as selection 
criterion was based on observations of Lue et al., who stated that a positive 
papaverine-test rules out veno-occlusive dysfunction reliably and McMahon et al. 
who found a statistically valid correlation between a negative test and veno-occlusive 
dysfunction.[2, 3] The validity of a (repeat) papaverine-test as a selection criterion 
for veno-occlusive function is corroborated in this study by the significant differences 
between groups A and В for all cavernosometry parameters (table 3). 
The presented data shed light on three aspects of cavernosometry: 1) the 
variability of the smooth-muscle relaxing effect of papaverine (this study) and other 
vasoactive agents (the literature), 2) the accuracy of parameters used in the 
diagnosis of veno-occlusive function and 3) the technique and similarity of 
veno-occlusive findings in gravity- and pump-cavemosometry. 
1) Variability of smooth-muscle relaxing effect A repeat trial with 50 mg of 
papaverine under the same circumstances (office) resulted in a positive erectile 
response in 2 1 % of the patients, who responded negative on a previous trial. This 
finding highlights the inconsistency of the papaverine effect and demonstrates that 
the reliability of the papaverine-test as screening test may be enhanced by repetition 
(figure 3). We found that the variability of response to papaverine is even more 
pronounced when papaverine is used in different circumstances (office -
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cavernosometry). At the time of cavernosometry, the steady state intracavernous 
pressure following injection of the vaso-active agent (ICP) is a measure of smooth-
muscle relaxation. In a state of complete cavernous smooth-muscle relaxation ICP 
equals the cavernous artery pressure less the loss of pressure from cavernous veno-
occlusive function.[5] An ICP of 50 mmHg is considered to be a minimal 
requirement for a full erectile response.[12] According to this criterion complete 
cavernous smooth muscle relaxation was noted in only 19 per cent of our controls at 
the time of cavernosometry. The failure to produce smooth-muscle relaxation is due 
to anxiety, resulting in a high adrenergic constrictor tone.fl, 17] 
As demonstrated by the differences between the reference values in the literature 
and in this study, variability of cavernous smooth-muscle relaxation is related to the 
vaso-active agent used and constitutes an important bias in the interpretation of 
cavernosometry. Apparently, the chance of incomplete smooth-muscle relaxation at 
the time of cavernosometry is particularly high when papaverine is used as mono-
substance (table 4).[5, 6, 9, 10, 12-16] Based on those findings, to date, at our 
institution the combination of papaverine, phentolamine and PGE1 and when 
necessary visual sexual stimulation and mechanical penile vibration are used to 
reduce adverse psychological influences and facilitate maximal cavernous smooth-
muscle relaxation at the time of cavernosometry.[18] Perhaps, the advent of penile 
electromyography (a method to quantify penile smooth-muscle activity) will make 
possible controlled pharmacological cavernous smooth-muscle relaxation in the 
future.[19] 
2) fhe accuracy of parameters In table 5 the Mahalanobis distance and the 
discriminating ability of cavernosometry parameters between groups A and В are 
depicted. The higher the Mahalanobis distance and the lower the percentage of 
misclassification, the higher the diagnostic value. It is apparent that maintenance 
flow (MF) and steady state intracavernous pressure at the time of gravity-
cavernosometry (ICPg) have the highest diagnostic value. This finding is explained 
by the physical principles involved in cavernosometry: The function of veno-occlusion 
is reflected by venous resistance of the cavernous body. When cavernous volume 
and pressure are constant, venous resistance is a function of inflow (arterial and 
external source). When intracavernous pressure is constant at a suprasystolic level, 
arterial inflow equals zero and venous resistance is linearly related to the flow rate 
of the external inflow source. When a rollerpump is used the flow rate is 
determined by the investigator. When gravity infusion is used, the flow rate is 
proportional to the pressure gradient between infusion pressure and intracavernous 
pressure as long as free flow delivery is guaranteed. Since the calibre of the needle 
used is always the same, the flow delivered is constant and can be directly 
calculated from the pressure gradient. Because MF and ICPg are measured at 
constant cavernous volume and pressure they accurately reflect venous resistance. 
However, if ICPg does not reach a suprasystolic level, additional arterial inflow will 
persist and cause an overrating of venous resistance. This may explain the fact that 
we found ICPg to be less accurate than MF. As expected, pressure volume response 
(PVR) and pressure loss (PL) appeared to be least reliable. This is explained by the 
fact that both parameters are determined at a time that cavernous volume and 
pressure are variable. Therefore both parameters depend on elastic properties of 
the cavernous body, which on their turn depend on variable factors such as aging, 
diabetes mellitus and vascular ischemia.[20-22] 
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3) Gravity- and pump-cavemosometry We inserted the needles at the base of the 
penis, because in an uncircumcised male, puncturing at that site is easier and pain 
sensation less pronounced than in the subcoronai groove. If an oblique insertion is 
chosen, with the needle pointing towards the crus, dislocation is rare. At the time of 
gravity-cavernosometry no needle dislocation was encountered, whereas at the time 
of pump-cavemosometry it occurred in 4 patients. The higher risk of dislocation at 
the time of pump-cavernosometry is due to the unphysiological change from the 
flaccid to the rigid state, causing rapid movements of the base of the penis and the 
high infusion rates at high pressures causing jetflow at the needle tip, driving the 
cavernous body off of the needle. Figure 4 depicts the correlation between the 
parameters of gravity- (ICPg) and pump-cavernosometry (ICPg) The correlation of 
the parameters of both methods appears sufficient enough to conclude that gravity-
cavernosometry is a useful alternative for pump-cavernosometry 
The authors conclude, that in cavernosometry the conventional rollerpump may be 
replaced by an infusion set. The method has the advantage of cost-effectiveness and 
has a lower nsk of complications. In case visualization of draining veins is required, 
a radiographic contrast agent may be infused and pictures taken at steady state 
ICPg. 
As long as controlled pharmacological cavernous smooth-muscle relaxation is not 
feasible, the use of a combination of potent pharmacological agents at an empirical 
dosage is necessary to obtain complete smooth-muscle relaxation at the time of 
cavernosometry. 
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Abstract 
One-hundred-twenty-three patients with complaints of erectile dysfunction and 
without clinically overt neurological disease underwent a comprehensive neuro-
urophysiological diagnostic work up. The results were compared with those obtained 
in 50 healthy volunteers. Data gathered consisted of somatosensory evoked 
potentials from the posterior tibial nerve (tibial evoked potential), and from the 
dorsal penile nerve (pudendal evoked potential). Also two sacral reflex latencies 
were measured (bulbocavernosus reflex and urethro-anal reflex). Fifty-eight patients 
(47%) showed at least one abnormal neuro-urophysiological measurement. Neuro-
urophysiological abnormalities were found more frequently in older patients. The 
tibial evoked potential was abnormal in 30 patients (24%), the pudendal evoked 
potential in 21 patients (17%), the bulbocavernosus reflex in 26 (21%), and the 
urethro-anal reflex in 32 (26%). It was concluded that somatosensory disturbances 
constitute an important part of neuro-urophysiological abnormalities. The results of 
this study suggest a relationship between erectile dysfunction and subclinical, age-
related (penile) sensory disorders. This study corroborates the importance of penile 
sensibility for erectile (patho)physiology as suggested by other authors, and supports 
the concept of sensory-deficit impotence as an important cause for erectile 
dysfunction. 
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Introduction 
Many authors have stressed the importance of evoked potentials for the diagnosis of 
neurological disorders of the urogenital tract. Bradley et al. used urethral 
electromyography to delineate neuropathic involvement of the lower urinary tract in 
neurological disease.[1] Ertekin and Reel found the bulbocavemosus reflex to be of 
great value in the differential diagnosis of urogenital tract dysfunction.[2] Siroky et 
al. and Krane and Siroky obtained excellent correlation between prolonged latency 
of the bulbocavemosus reflex and clinical evidence of neuropathy in patients with 
suspected neurological disease (diabetes mellitus, multiple sclerosis, Miles' resection 
of the rectum, herniated disk and toxic neuropathy). [3, 4] Haldeman et al., Badr et 
al, and Opsomer et al. were able to obtain cortical evoked potentials after 
stimulation of both somatic and visceral peripheral nerves.[5-7] Anten et al. 
described the possibility of localizing neurological lesions in patients with urologica! 
dysfunctions by combining somatic and visceral evoked potentials with sacral reflex 
latencies.[8] 
Evoked potentials and sacral reflex latencies have been used as a diagnostic tool 
in neurological patients with erectile dysfunction (ED) by Lin and Bradley, Buvat et 
al., Ertekin et al., and Tackmann et al..[9-12] However, none of these authors used 
the combination of somatosensory evoked potentials with the latency of the urethro-
anal reflex and the bulbocavemosus reflex. In this study we tried to relate findings 
of a comprehensive neurophysiological diagnostic work up, which consisted of a 
combination of somatosensory evoked potentials and sacral reflex latencies, to 
clinically relevant parameters such as age, medical history, intoxications, outcome of 
intracavemous pharmacotest and hormonal profile in 123 neurologically unsuspected 
patients. 
Materials and Methods 
For this study we examined 171 consecutive patients (mean age, 52 years; range 17-
77 years) with complaints of erectile dysfunction (ED). From each we took a 
detailed history focusing on sexual function, neurological disease, and potential toxic 
factors such as smoking of cigarettes, alcohol abuse, or exposure to neurotoxic 
chemicals. Based on history and physical examination, 48 patients were excluded 
from this study, because a neurological etiology for ED was suspected: Twenty-one 
patients with diabetes mellitus, twenty-one whose ED appeared immediately after 
surgical intervention in the pelvis (radical prostatectomy, transurethral prostatic 
resection, or sigmoid resection), and six who became impotent after laminectomy 
because of herniated disc. 
None of the patients included in this study complained about numbness or other 
sensory disorders, neither in the genitalia nor in the hands or feet. Physical 
examination revealed no indication for neurological disease. 
In each patient an intracavemous pharmacotest (papaverine-hydrochloride) was 
performed with an initial dosage of 50 mg. Because induction of erection by 
papaverine injection may be influenced by external factors like stress and anxiety, a 
negative papaverine test was repeated once at a later occasion to increase its 
diagnostic accuracy.[13] In all patients with an erectile response to 50 mg 
papaverine, the erectile response to 25 mg was tested. 
Blood samples were taken for plasma levels of testosterone, luteinizing hormone, 
prolactin and plasma-glucose. 
Evoked potentials were obtained with a commercially available stimulation and 
registration apparatus. Neuro-urophysiological studies consisted of measurement of 
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the tibial evoked potential (ТЕР), pudendal evoked potential (PEP), 
bulbocavernosus reflex (BCR) latency, and urethro-anal reflex (UAR) latency (figure 
1). Fifty healthy male volunteers without complaints of ED were investigated as a 
control group. 
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Figure 1 Neuro-urophysiologic measurements and neural pathways 
Neuro-urophysiological investigations were done with the patients in the supine 
position, in a room with a constant temperature of 25 "C. The somatosensory 
evoked potentials were obtained with bipolar percutaneous stimulation (number of 
stimuli, 200; stimulus duration, 0.2 ms; frequency, 2.7 Hz) of the posterior tibial 
nerve at the ankle of the right foot (ТЕР), and the dorsal penile nerve on the 
dorsum of the shaft of the penis (PEP), with the cathode proximal to the anode. 
For ТЕР stimulation intensity was considered accurate if twitching of the toes was 
clearly visible; for PEP stimulation intensity was at least twice the sensory threshold. 
The evoked potentials were recorded with silver plated cup electrodes from the Cz-
2 point (2 cm behind Cz) determined with the international 10-20 system.[14] 
Electrode resistance was kept below 1.5 kn. We averaged 200 stimuli (high 
frequency filter setting at 1500 Hz; low frequency filter setting at 50 Hz; sensitivity, 
100 д ). Latency time was defined as P, at the first positive (downward) deflection 
of an averaged curve. All curves were measured twice to check repeatability. Curves 
in which the cortical response could not be identified were classified as "non-
evokable". 
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We also determined sensory thresholds to electrical stimulation of the mucosa of 
the proximal urethra using an indwelling balloon catheter with two ring electrodes 
10 and 20 mm from the base of the balloon. After insertion into the bladder and 
filling of the balloon the catheter was retracted, allowing direct electrical stimulation 
of the urethral mucosa. The sensory threshold was defined as the lowest level (in 
mA) at which a patient could feel the square-wave pulses (stimulus duration, 0.2 ms; 
frequency, 1.3 Hz) as a throbbing or burning sensation. This measurement was 
repeated three times, taking the lowest value as the sensory threshold. During the 
whole procedure continuous bladder drainage was warranted by a drainage bag 
attached to the catheter. 
To measure BCR latency, penile stimulation was done on the penile shaft as in 
PEP. Recording was in the right ventral quadrant of the external anal sphincter 
muscle with a concentric needle electrode, a technique favoured by Hassouna et 
al..[15] To measure UAR latency, we stimulated the proximal urethra and recorded 
the response as for the BCR. For both sacral reflexes, 8 separate latency 
measurements were recorded using supra-maximal square-wave stimuli of 60 mA 
(stimulus duration, 0.2 ms). Thus, consistent and repeatable measurements were 
obtained. If measurement of a sacral reflex latency (BCR, UAR) revealed a delayed 
or absent response, the EMG-needle was reinserted into the left ventral quadrant 
and the recording was repeated. In that case shortest latency was used for further 
evaluation. For this study only those sacral reflexes were considered "abnormal" in 
which repeated recordings gave delayed or non-evokable responses. 
In all patients, we recorded the electro-myographic activity of the anal sphincter at 
rest and at voluntary contraction, to check needle-localization. Special attention was 
paid to electro-myographic signs of denervation, such as fibrillation potentials, 
positive sharp waves and polyphasic potentials. 
In order to check reproducibility of the neuro-urophysiological technique, we 
repeated the complete investigation in 10 randomly selected patients with a time 
interval of 6 weeks to 6 months between consecutive investigations. All patients gave 
informed consent to a second test. Reproducibility was calculated using the 
coefficient of reliability. [16] Determination of reliability took into account 
instrumental and physiological variations within a patient between time-points as 
well as biological variations between patients. 
On the basis of reference values found in 50 healthy male volunteers with a 
history of normal erectile potency, we distinguished between normal and pathologic 
results of the neuro-urophysiological investigations and formed two groups. Group I 
consisted of patients without abnormal neuro-urophysiological findings, and group II 
of patients with at least one neuro-urophysiological measurement above the normal 
range. Non-evokability in somatosensory evoked potential or sacral reflex latency 
measurement was considered pathological, because this phenomenon was never seen 
in the 50 volunteers. Patients in whom it occurred were placed in group II. 
For statistical comparison of two sample-percentages Fishers exact test (two-tailed) 
was used and for the comparison of two sample-distributions of an (at least) ordinal 
variable the Wilcoxon two-sample test was appropriate. If the p-value of the 
statistical test was smaller than or equal to 0.05 the difference between the two 
samples was called "statistically significant". 
Results 
The results of the measurements of somatosensory evoked potentials and sacral 
reflex latencies in the 50 volunteers are given in table 1. Our reference values are 
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well in accordance with those reported in the literature. The mean age of the 
control group was 45 years (range, 29-62 years). Sixty-five of the 123 patients (53%) 
were without any abnormal finding (group I), whereas 58 patients (47%) showed 
one or more abnormal latencies (group II). The mean age of the 65 patients in 
group I was 49 years (range, 26-68 years) and for the 58 patients in group II it was 
54 years (range 23-77, years). The age differences between group I and group II are 
statistically significant (Wilcoxon two-sample test, ρ = 0.038). Age dependence of 
neuro-urophysiological abnormalities is also illustrated in table 2. In the patients 
with normal or delayed evoked potentials, it was easy to obtain several curves, with 
a consistent and repeatable Ρ,-latency. In those, in whom the response was not 
clearly evokable, repeated measurements consistently remained unidentifiable. 
Table 1 Normal values in 50 healthy males (mean age, 45 years; range 29 - 62) 
Response normal range 
(mean ± 2sd) 
Tibial Evoked Potential (ТЕР) 35 - 46 ms 
Pudendal Evoked Potential (PEP) 36 - 47 ms 
BulboCavernosus Reflex (BCR) 20 - 40 ms 
Urethro-Anal Reflex (UAR) 46 - 75 ms 
ТЕР was delayed or non-evokable in 30 out of 123 patients (24%), and PEP in 21 
patients (17%). So peripheral neuropathies contributed importantly to the high 
amount of abnormalities found in this study. Affliction of the central (supra-sacral) 
neuraxis seemed less important, because in only 4 patients the combination of 
abnormal ТЕР and PEP, together with normal BCR and UAR was found. Also the 
poor correlation between ТЕР and PEP in the patients of group II (Kendall's 
correlation coefficient, 0.12) suggested little importance of supra-sacral lesions in our 
Table 2 Tlie relationship between age and neuro-urophysiological abnormalities 
Age (years) η Abnormal % 
NUPHI 
23 - 39 21 7 33 
40 - 49 33 15 45 
50 - 59 41 20 49 
60 - 77 28 16 57 
Total 123 58 47 
patients, since both evoked potentials travel along the same supra-sacral neural 
pathway. If lesions would have been localized in the supra-sacral neural pathway 
(i.e. dorsal columns, see figure 2), correlation would have been high. In a similar 
study on 40 patients with definite multiple sclerosis, a disease know for afflicting 
central neural pathways, we found a correlation coefficient for ТЕР and PEP of 
0.50.[17] 
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Figure 2 Schematic overview of 
peripheral and central neural pathways 
for TEP and PEP 
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abnormal in 32 patients (26%). 
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The median value of the sensory 
threshold of the proximal urethra was 8 
mA (range, 2-61) in the 65 patients of 
group I, and 14 mA (range, 2-74) in the 
58 patients of group II (p = 0.08). So 
although the differences in urethral 
sensitivity between normal and abnormal 
patients with ED are sizeable, this 
measurement seems not very valuable for 
use in clinical practice because of the 
wide range of values in both groups. 
On insertion of the concentric 
electromyography needle, all patients 
showed normal insertion activity. With 
voluntary contraction of the external anal 
sphincter, all patients showed an 
interference pattern on EMG registration, 
indicating correct needle placement and 
fair function of central and peripheral 
motor pathways. No signs of denervation 
abnormal in 26 patients (21%). UAR was 
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The combination of abnormal sacral reflexes (UAR and/or BCR) and normal 
evoked potentials (ТЕР and PEP) was found in 18 patients. Therefore, besides 
peripheral neuropathy, sacral neuropathic involvement was remarkable frequent in 
our patients. 
Kendall's correlation coefficient for BCR and UAR measurement was 0.20 in the 
patients of group I, and 0.18 in the patients of group II. So abnormal BCR was not 
necessarily accompanied by abnormal UAR, and vice versa. 
Figure 3 gives an overview of all combinations of abnormal measurements. The 
results of the repeated measurements in 10 randomly selected patients are given in 
table 3. 
Table 3 Comparison of latencies of repeated ТЕР, PEP, UAR and BCR measurements 
in 10 randomly selected patients, (ne = поп-е окаЫе) 
Patient 
J.V. 
P.J. 
J.D. 
J.L. 
J.M. 
P.C. 
C.B. 
H.S. 
L.J. 
P.J. 
age 
52 
64 
55 
42 
60 
31 
30 
67 
57 
46 
reliability 
1st 
43 
42 
64 
55 
56 
43 
44 
49 
43 
44 
ТЕР 
2nd 
43 
42 
63 
52 
55 
46 
44 
49 
42 
44 
0.99 
latencies (msec) 
1st 
48 
41 
44 
53 
44 
41 
36 
ne 
45 
41 
PEP 
2nd 
47 
43 
44 
50 
44 
44 
38 
ne 
43 
39 
0.95 
1st 
73 
53 
57 
80 
ne 
59 
64 
66 
67 
59 
UAR 
2nd 
61 
53 
64 
85 
ne 
59 
70 
64 
69 
62 
0.89 
1st 
39 
28 
32 
33 
37 
33 
38 
41 
31 
27 
BCR 
2nd 
38 
28 
32 
37 
38 
28 
35 
41 
27 
27 
0.93 
Coefficients of reliability were 0.99 for ТЕР, 0.95 for PEP, 0.89 for UAR, and 
0.93 for BCR. These figures show excellent agreement between consecutive 
measurements. Reproducibility of the neuro-urophysiological technique therefore 
seems to be beyond any doubt. 
Smoking habits were recorded in 106 patients. Of our patient population 48 
patients (45%) were heavy smokers (more than 10 cigarettes daily). Of these 48 
heavy smokers, 20 (42%) had an abnormal neuro-urophysiological investigation, 
whereas of the 44 non-smokers, 19 (43%) had an abnormal investigation. Obviously, 
the outcome of the neuro-urophysiological investigation did not depend on smoking 
habits. 
A pharmacotest was performed according to the above mentioned criteria (i.e. at 
least one repetition of the test after a previous negative one) in 117 patients. It 
showed adequate rigidity in 71 patients, it was consistently negative in 46. In none 
of the patients a prolonged erection (longer than 6 hours) or priapism was seen. In 
all of the 71 patients with a positive papaverine test we tried to bring down the 
dosage to 25 mg, with erection remaining adequate. This succeeded in 17 patients. 
Comparison of the outcome of the neuro-urophysiological investigation in these 17 
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patients with 54 patients, who consistently needed 50 mg for full rigidity, is given in 
table 4. No relation was found between the dosage necessary to gain full rigidity at 
pharmaco-testing and the outcome of the neuro-urophysiological investigation. 
Table 4 The correlation between the outcome of the neuro-urophysiological 
investigation (NUPHI) and the response to intracavemous papaverine injection, 25 mg 
and 50 mg respectively (n=117) 
Response to 
Papaverine 
Positive 
Positive 
Negative 
Dosage 
(mg) 
25 
50 
50 
Normal NUPHI 
n ( % ) 
9(53) 
27 (50) 
24 (52) 
Abnormal NUPHI Total 
η (%) η ( % ) 
8(47) 
27 (50) 
22 (48) 
17 (100) 
54 (100) 
46 (100) 
Out of 100 patients of whom complete hormonal profiles were available, 11 had 
abnormal levels of testosterone (less than or equal to 11 nmol/1). No abnormal 
levels of luteinizing hormone, prolactin, and plasma-glucose were found. Of these 11 
patients with low testosterone levels, 5 had normal neuro-urophysiological 
measurements, and 6 had deviant measurements. So, from these figures no influence 
of testosterone levels on the outcome of the neuro-urophysiological investigation 
could be concluded. 
Discussion 
The neuro-urophysiological examination presented here was well tolerated by 
patients. It was our experience that it takes some time for the clinical investigator to 
familiarize with the technique. Extensive information to the patient, together with an 
understanding and supportive approach, added to a high degree to the success of 
the investigation. After a learning curve, this technique appeared to be easy to 
perform and reproducible. 
In comparison to 50 volunteers with normal erectile potency, the combination of 
investigatory techniques for somatic and visceral neuro-urological pathways, revealed 
abnormalities in 58 of 123 impotent patients (47%). Using the same normal values, 
Porst et al. found even higher numbers of abnormalities (up to 66%) on 
investigation of somatic tracts (PEP and BCR) only.[18] On statistical grounds one 
or more abnormalities can be expected within a normal group in up to 9.6% (i.e. {1 
- 0.9754} χ 100%) when four measurements, each with a specificity of 97.5%, are 
combined. This means that the finding of 47% abnormalities is impossibly due to 
hazard. 
In our study delayed stimulus conduction and processing along peripheral and 
sacral neural pathways proved to be related to age to a statistical significant degree. 
Edwards and Husted suggested collagen infiltration, atherosclerotic malnutrition and 
progressive peripheral neuropathy as possible causes for age-related decrease of 
penile sensitivity and decline of sexual activity.[19] Our study supports the 
suggestion of Edwards and Husted, that peripheral neuropathy and decrease of 
penile sensitivity are causally related to ED. It was shown above that peripheral 
neuropathy together with sacral neurological disturbances account for the major part 
of the abnormalities. These disturbances are localized in the sensory neural 
pathways. For peripheral tibial and pudendal nerves this is obvious, because ТЕР 
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and PEP deal with sensory nerves only For penile innervation this proof is derived 
from neuro-anatomy: Afferent nerves of UAR and BCR run along two distinct 
pathways: Autonomic pelvic nerve fibers for UAR and somatic pudendal nerve 
fibres for BCR.[1, 5, 20] In the sacral spinal cord autonomic neurons are 
distinguishable from somatic neurons [21] For both sacral reflexes motor outflow 
goes through pudendal nerve fibres (see figure 1) So although closely related, BCR 
and UAR reflect different afferent pathways of uro-genital tract innervation. The 
absence of any significant correlation between pathological autonomic reflexes 
(UAR) and abnormal somatic reflexes (BCR) (Kendall's correlation coefficient, 0.18) 
suggests that the neurological impairment in our patients is localized in the afferent 
(sensory) limb; it also shows that both the somatic and visceral afferent limbs of the 
reflex arcs can be afflicted separately 
Another argument for the importance of sensory disorders is found in the 
outcome of the urethral sensory threshold measurements, that revealed higher 
sensory thresholds in patients with neuro-urophysiological abnormalities. 
The importance of penile sensory input for physiology of erection was underlined 
by Herbert, who in a study on the rhesus monkey showed that sexual activity, and 
the ability to ejaculate was dependent on dorsal (sensory) penile nerve function.[22] 
With respect to the physiological explanation it was stated that sensory input from 
the genitalia arouses central reflexogenic erectile mechanisms Genital sensory input 
also evokes psychogenic sexual responses, and consequently stimulates sexual 
responsiveness 
Regarding this important role of penile sensitivity in the physiology of erection, 
the high incidence of age-related sensory disorders in a sub-population of 58 
impotent men indicates that sensory-deficit impotence, a concept first introduced by 
Padma-Nathan, may be an important causal factor of ED in the elderly.[23] Sensory-
deficit impotence refers to impotent males with abnormal PEP and BCR studies. 
Clinically these patients merely suffer from weak erections of too short duration and 
from ejaculatory difficulties, than from pure absence of tumescence and rigidity. 
The concept of sensory-deficit impotence is supported by the findings of Lavoisier 
et al.. In a study on 19 patients with abnormal BCR measurements, they found 
normal erections on nocturnal penile tumescence monitoring (NPT) in 8 
patients [24] Because of this finding they concluded that measurement of BCR 
latency is not accurate for the diagnosis of neurogenic impotence. To our opinion, 
however, the combination of abnormal BCR and normal NPT does not exclude a 
neurogenic cause tor ED, because patients with sensory-deficit impotence are likely 
to have normal NPT studies In fact all 19 patients with penile sensory disturbances 
on BCR studies had some kind of erectile potency left: Not only the 8 with normal 
NPT, but also the 11 patients with "abnormal" NPT were reported to have nocturnal 
periods of penile rigidity. Obviously, all 19 patients suffered from sensory-deficit 
impotence. 
Our study, which shows a remarkable high number of abnormal PEP, UAR and 
BCR latencies, and the studies as quoted above, all seem to prove the presence and 
the clinical importance of subclinical sensory disorders of the penis in impotent men. 
Surely, more fundamental research is needed to elucidate the exact clinical 
implications of these findings, as well as their precise nature and cause. 
Apart from the process of aging, no clue to the underlying cause of sensory 
disorders was found. After all, all patients, who because of their histories were likely 
to have neurogenic impotence were excluded from this study Bradley et al. and 
Ertekin and Reel suggested the possibility of cortical interference with sacral reflex 
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latency.fl, 2] Their findings are not confirmed by our study, because no correlation 
was found between BCR and UAR. One would expect these cortical influences to 
have equal impact on both sacral reflexes. Also the excellent reproducibility of the 
measurements is in contradiction with some kind of suprasacral interference. 
Smoking habits did not cause neuro-urophysiological abnormalities. Besides 
smoking of cigarettes, perhaps contact of individual patients with tone agents at 
work or at home (food, or environment) is important. Indeed, we found that one 
42-year-old patient, who had been working with neurotoxic chemicals for many 
years, had gross neuro-urophysiological deviations. In three other cases of long 
lasting alcohol abuse, abnormal neuro-urophysiological measurements proved toxic 
neuropathy. 
Apart from the latter four cases, no new diagnoses were made. None of the 
patients with neuro-urophysiological abnormalities had unsuspected neurological or 
other disease (e.g. diabetes mellitus) 
According to Padma-Nathan some kind of denervation supersensitivity could be 
expected in neurologically impaired patients, with a higher frequency of neurological 
abnormalities in patients with a positive papaverine test [23] And Sidi et al stated 
that men with neurogenic impotence have dn increased sensitivity to vasoactive 
pharmaco-therapy.[25] We were not able to corroborate these findings: The 17 
patients who responded with adequate rigidity on intracavernous injection of 25 mg 
papaverine-hydrochloride had equal neurophysiological abnormalities as the 54 in 
whom 50 mg were necessary This can be explained by the fact that denervation 
supersensitivity to pharmaco-stimulation is a concomitant sign of motor-deficit 
impotence, whereas our study revealed sensory-deficit impotence only. As far as 
pelvic floor-EMG is a reflection of motor neuron function, the absence of any 
abnormality on EMG-studies makes motor-deficit impotence in our patients less 
likely. However, for the evaluation of motor-deficit impotence penile 
electromyography, a technique recently introduced by Wagner et al , seems more 
reliable than pelvic floor-EMG.[26] 
Conclusion 
This study revealed that in patients with ED but no clinical signs of neurological 
disease, many more sensory disturbances were found on neuro-urophysiological 
investigation than could be expected by hazard This suggests a causal relationship. 
From a clinical point of view, under the surface penile sensory disorders are much 
more frequent than clinicians assume from their clinical observations. Our study also 
proves that distinction should be made between sensory- and motor-deficit 
impotence. 
Fundamental research is needed to elucidate the short- and long-term implications 
of the detected abnormalities. The anatomical substrate can perhaps be identified by 
histologic or neurotransmitter studies on tissues of the urogenital system. Also the 
effect of environmental factors such as smoking of cigarettes, use of drugs and other 
neuro-toxic agents remains subject for further investigation. From a therapeutical 
point of view it seems worthwhile to investigate whether patients with sensory 
disorders have decreased plasma-levels of folic acid, vitamin B-6 or B-12. Such a 
finding would provide a rationale for pharmacological treatment. 
Since the outcome of our comprehensive neuro-urophysiological tests had no 
consequences for the therapeutic assessment of individual patients, the use of 
elaborate studies of this kind in patients without a history of neurological disease 
seems limited to scientific purposes, at least for the moment. 
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Abstract 
The trabeculae of the cavernous body are composed of smooth muscle and 
fibroelastic tissue. Disturbance of the relationship between these components due to 
atrophy and loss of smooth muscle cells may cause dysfunction of the cavernous 
body (end-organ disease). Determination of the degree of end-organ disease may 
contribute to the selection of candidates for surgery of the penile vascular in- and 
out-flow tract. We quantified the volume percentages of smooth muscle and fibrous 
tissue in a post-mortem study in 17 subjects, to assess the potential use of 
histomorphometric analysis of needle biopsies of the cavernous body. 
We conclude that histomorphometric analysis reveals a significant and generalized 
age-related decrease of cavernous smooth muscle content due to fibrosis. However, 
the biological variation between individuals is too large to expect that 
histomorphometric analysis will contribute to clinical diagnosis. Moreover, acquisition 
of penile needle biopsies appeared to be an impossibility. 
These findings express the need for further research and clinical experimentation 
before a penile biopsy can be used as a clinical tool in the assessment of end-organ 
disease. 
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Introduction 
The smooth muscle cell, as the main contractile-relaxing entity of the cavernous 
body, plays a key-role in penile erection.[l] Therefore, atrophy and loss of function 
of smooth muscle cells may eventually lead to failure of the cavernous body (end-
organ disease). 
Although current clinical diagnostic tests have improved the understanding of the 
patho-physiology of penile erection, methods to assess the function of the cavernous 
body directly are still not at our disposal. Due to this limitation the selection of 
candidates for surgery of the penile in- and out-flow tract is difficult and this may 
explain the low rates of success of these types of surgery.[2, 3] Obviously, at present, 
many patients with unrecognized end-organ disease are subjected to surgery of the 
in- and out-flow tract. The advent of diagnostic techniques to assess disease of the 
cavernous body will certainly result in higher surgical success rates.[4] 
Recently, much attention has been focused on morphological investigation of 
cavernous tissue as a tool in the diagnosis of end-organ disease. Correlations have 
been found between clinically diagnosed erectile dysfunction and structural and 
ultrastructural changes of the cavernous body.[5-7] These studies emphasize the 
importance of the concept of end-organ disease. They, however, will not be of much 
clinical value as long as the acquisition of cavernous biopsies remains a (major) 
surgical procedure. 
In an effort to find a simple and less invasive method to acquire and process 
cavernous tissue we investigated the usefulness of a biopsy instrument to obtain 
tissue and assessed the accuracy of histomorphometric analysis of these tissue 
samples. 
Material and Methods 
To assess the clinical value of histomorphometric analysis of cavernous tissue, we 
performed a study of 17 cavernous bodies. The specimens were removed during 
autopsy from subjects between 31 and 78 years old, who died of various causes 
without any direct involvement of the genital tract. The sexual history of the subjects 
was unknown. The cavernous bodies were resected as close as possible to the 
urogenital diaphragm. Skin and glans of the penis were not removed. After fixation 
in 10% buffered formalin, the specimens were lamellated from distal to proximal 
into 4-5 mm. thick segments, which were embedded in paraffin after routine tissue 
processing. The segments were cut in 5 μπι sections and stained with 
haematoxylin-eosin and Masson's trichrome-staining. 
Histomorphometry 
Two histomorphometric parameters were used to quantify changes in the trabecular 
compartment of the cavernous body: volume percentage of smooth muscle and 
volume percentage of fibrous tissue. These parameters were determined in the 
proximal and distal part of the cavernous body. The volume percentages of 
smooth-muscle and fibrous tissue were assessed with computer assisted 
point-counting technique. [8] The equipment used for point-counting consisted of a 
personal computer and a microscope equipped with a projection head containing a 
translucent 42-point coherent Weibel multipurpose grid.[9] A 25X objective was 
used. To obtain the volume percentages of the smooth muscle tissue and fibrous 
tissue of proximal and distal parts of the cavernous body, each of the two cavernous 
bodies were systematically sampled with S test fields: in total 10 test fields in a 
section of the most proximal part of the cavernous body and 10 test fields in a 
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section of the most distal part of the cavernous body. In each test field the 
grid-points hitting smooth-muscle tissue and fibrous tissue were counted (figure 1). 
Figure 1 Transverse segment of the cavernous body stained with Masson's 
trichrome-staining. Magnification 25X. A translucent 42 point coherent Weibel multi-
purpose grid is superimposed 
Statistics 
The age-dependencies of the histomorphometric parameters were described with a 
linear regression model. The validity of this linear regression model was tested in a 
polynomial regression analysis. Parallelism of the regression lines of the 
histomorphometric parameters of the proximal and distal parts of the cavernous 
body, differences in histomorphometric parameters of proximal and distal parts, and 
dependence on age of the parameters were studied in a linear regression analysis. 
Penile biopsies 
To investigate the usefulness of a biopsy needle to obtain cavernous tissue, we 
performed 5 punctures in 3 subjects, using a "Biopsy-instrument"(Radiplast AB, 
Uppsala, Sweden): before resection of the cavernous bodies the skin of the penis 
was punctured at the base of the penis. The needle-point (biopsy-needle, diameter 
18 gauge) then was pressed against the tunica albugínea and the gun was fired 
transversely. 
Results 
The polynomial regression analysis performed on the two histomorphometric 
parameters showed no significant improvement of the linear fit when higher order 
terms in age were added. Therefore the age-dependent changes could be described 
by a linear regression model. Regression analysis revealed that the regression 
coefficients of the histomorphometric parameters for the proximal and distal parts 
of the cavernous body did not differ significantly (p=0.38) and that the differences 
between the proximal and distal parts of the cavernous body were not statistically 
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significant (p=0.28). Therefore the pooled data of proximal and distal cavernous 
body were used to describe the age-dependency of the histomorphometric 
parameters. 
The regression lines of the histomorphometric parameters of the proximal and 
distal part are given by the formula: Yprall™l=YdiÄI= A + Β χ age. For the volume 
percentage of cavernous smooth muscle tissue and fibrous tissue a significant (p < 
0.0001) dependency of age was found and the absolute value of the regression 
coefficients В of the regression lines of both volume percentages were almost equal 
( | В | = 0.33 +_ 0.07). The intercept A and the standard error of A of the regression 
line of the percentage of smooth muscle tissue are given by (74.4 +. 3.8). The 
regression line and its 95% prediction interval for the volume percentages of 
cavernous smooth muscle are given in figure 2. According to the linear regression 
model the estimated mean volume percentage of smooth muscle content in 30-year-
old subjects is 65% and in 80-year-old subjects 48%. The overall standard deviation 
of the volume percentage smooth muscle is approximately 11%, whereas the 
difference in the mean volume percentage smooth muscle between young men (30 
years) and old men (80 years) is 17%. 
Puncture biopsies: In 5 punctures we were not able to obtain cavernous tissue. 
Volume percentage smooth muscle 
Distal û 
Proximal • 
¿0 50 60 70 80 Age (years) 
Figure 2 The regression line and its 95 per cent prediction interval for the volume 
percentage of cavernous smooth muscle content in relation to age 
Discussion 
The use of penile biopsies to support the clinical diagnosis of erectile dysfunction is 
justifiable if the following conditions are met: 1) damage caused to the cavernous 
body by acquisition of the biopsy should not exceed the diagnostic gain; 2) tissue 
samples should be representative. That means that the pathological process that is 
studied should be generalized throughout the cavernous body so that its expression 
does not depend on the site from which the biopsy is taken; 3) the biological 
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variation of the parameter that is measured should be small compared to the 
variation that is caused by the pathological process. 
The acquisition of penile biopsies by open surgery deserves a word of caution. 
Access to the cavernous body is difficult. The neurovascular bundle may be 
damaged and transection of the tunica albugínea may be complicated by scarring 
and subsequent deviation of the penis. Therefore, for routine diagnostic purposes 
open penile biopsies must be used judiciously. To find a method that would limit 
surgical damage, we investigated the use of a biopsy gun to obtain needle biopsies. 
Despite repeated efforts, however, it was impossible to obtain cavernous tissue. 
Apparently, we used a wrong technique of puncturing, because recently, Wespes et 
al. reported on the successful use of the biopsy-instrument. In his technique the 
point of introduction is the balano-prepucial groove on the dorso-lateral side. After 
puncturing the tunica albugínea the needle is fired longitudinally.[10] 
Due to anatomical variations, exact definition of the biopsy-site is not possible and 
diagnosis must be made on tissue specimens that are obtained randomly. Therefore, 
diagnosis will only be accurate if the expression of pathological changes does not 
differ between the different parts of the cavernous body. Histomorphometric 
parameters that were investigated in this study did not show significant differences 
between proximal and distal parts. This finding is in agreement with the current 
concept of cavernous disease: except for localized anomalities like Peyronie's disease 
and traumatic scarring, the majority of cavernous abnormalities are generalized. 
The population of this study was matched according to age. Although the group 
of subjects was relatively small and erectile potency unknown we could demonstrate, 
that aging is accompanied by generalized atrophy of smooth muscle tissue due to 
progressive fibrosis. This finding is in agreement with other investigators, and may 
explain the higher incidence of erectile dysfunction in the elderly.[7, 11, 12] 
Does this finding justify the use of conventional histomorphometric techniques to 
analyze cavernous biopsies? It should be emphasized that significant but only minor 
age-correlated decrease at cavernous smooth muscle tissue could be demonstrated 
(mean smooth muscle content in 30-year-old subjects 65% and mean smooth muscle 
content in 80-year-old subjects 48%), whereas a large biological variation between 
individuals was found (standard deviation of volume percentage of smooth muscle 
tissue of 11%). Therefore, histomorphometric assessment of cavernous smooth 
muscle volume seems not to be the method of choice to detect clinically significant 
end-organ disease. The finding is supported by Jevtich et al., who did not observe 
significant histomorphometric differences between impotent and normal men.[6] 
Conclusion 
In contrast to electron-microscopic techniques, light microscopic histomorphological 
assessment of cavernous smooth muscle content is not useful in the clinical diagnosis 
of erectile dysfunction. It can be expected that the use of staining techniques that 
rely on markers for cyto-skeleton, neurotransmitters etc. will enhance diagnostic 
accuracy of histomorphometry. The acquisition of cavernous tissue needs further 
experimentation before biopsies can be taken for diagnostic purposes. 
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Figure 1 An algorithm for diagnosing erectile dysfunction. NPTR: Nocturnal Penile 
Tumescence and Rigidity Recording. NUPHI: Neuro-UroPhysiological Investigation 
Diagnosing ED inherently involves repetitive demands for decision-making. The 
clinical diagnostic decisions in ED are characterized by the necessity for precision 
without having the luxury of routinely employing all tests available. Based on the 
results of the studies described in chapter 2-8 of this thesis, this chapter presents an 
algorithm for problem analysis and decision-making in erectile dysfunction. 
Comments 
A) The capacity for erection is less sensitive to testosterone withdrawal than is 
sexual interest and activity. The central processes that lead to spontaneous erections 
are androgen dependent, while mechanisms leading to erection in response to 
external erotic stimuli remain intact despite androgen deprivation. Hormonal 
screening of ED can be accomplished with measurement of serum testosterone 
levels alone. If the level is abnormal a more comprehensive endocrine evaluation 
becomes necessary (Chapter 2). 
B) The diagnosis of psychogenic ED is suspected on basis of the patients' history 
(acute onset related to a specific event, normal erections during masturbation, in 
non-coital situation or with other partners) and can be confirmed by a normal 
NPTR rating. A normal NPTR can confirm the diagnosis of psychogenic ED with 
the reservation that the presence of NPTR sufficient for vaginal intromission proves 
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diurnal erectile capability only in the absence of a neurological disorder (Chapter 2). 
C) The diagnosis of neurogenic ED is suspected on basis of the patients' history 
of inability to develop an erection. Moreover neurologic risk-factors (neurologic 
disease, pelvic surgery and disorders associated with peripheral neuropathy) may be 
encountered and the patient may demonstrate hyperreactivity to intracavernous 
pharmaco-stimulation (Chapter 2). However, for the diagnosis of neurogenic 
impotence, patients' history should not be used as the golden standard. Penile 
sensory deficit is encountered in a large proportion of impotent men without a 
history of neurologic risk factors (Chapter 7) and normal tests are found in 
suspected patients. 
Thus, neuro-urophysiological investigations (NUPHI) are used to confirm the 
diagnosis of neurogenic ED. More specifically the assessment of penile sensory 
disorders may be used to predict satisfaction following the various treatment 
modalities (reconstructive or penile implant surgery and autoinjection therapy). 
Reference values for NUPHI (Chapter 7) 
Tibial evoked potential ТЕР 35 - 46 ms 
Pudendal evoked potential PEP 36 - 47 ms 
Bulbocavernosus reflex BCR 20 - 40 ms 
Urethro-anal reflex UAR 46 - 75 ms 
D) An insidious progressive loss of erectile capabilities with consistent change in 
rigidity is indicative of vasculogenic ED. Usually the history reveals underlying 
vascular risk-factors (Chapter 2). If there is an inflow problem erections develop 
slowly and may not be sufficiently rigid enough for intercourse or masturbation 
except sometimes after extended foreplay or stimulation; sleep erections or erections 
upon awakening may appear more rigid. Veno-occlusive dysfunction is characterized 
by erections that are poorly maintained and not rigid enough for intercourse or 
masturbation. 
E) Penile pharmaco-duplex-ultrasonography is used as first line diagnostic 
technique to assess penile inflow capacity and veno-occlusion. 12.5 mg papaverine or 
10 \i% PGE1 result in optimal hemodynamic effects and have a low risk of 
prolonged erection (Chapter 5). Arterial inflow and veno-occlusion are determined 
in different phases of erection using different Doppler parameters (Chapter 3 and 
4). Inflow is assessed immediately following intracavernous pharmaco-stimulation, 
using peak flow velocity and acceleration time as most important parameters. 
Reference values for duplex ultrasonography (Chapter 4) 
Peak flow velocity 22 cm/s 
Acceleration time 122 ms 
Veno-occlusive function is estimated on the basis of patients' self-report of erectile 
response following duplex scanning (Chapter 5). 
F) In patients who are considered candidates for arterial and/or venous surgery 
(age < 50 years), pharmaco-duplex-ultrasonography is followed by both selective 
angiography and cavernosometry-graphy if parameters of inflow are abnormal. 
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G) If veno-occlusion is insufficient in the presence of normal inflow, duplex 
scanning is followed by cavernosometry-graphy alone. 
H) Cavernosometry-graphy can assess the dynamics of both penile inflow and 
veno-occlusion. The test is performed after complete relaxation of the cavernous 
smooth muscle. Intracavernous administration of 50 mg papaverine as mono-
substance is inadequate for this purpose. It is advised to use the combination 
papaverine (50 mg), phentolamine (2.5 mg) and PGE1 (10 /xg) (Chapter 6). 
The difference between occlusion pressure of the cavernous and brachial artery is 
used as parameter of the arterial inflow tract. A difference of over 36 mmHg is 
considered abnormal cavernous artery hemodynamic function (Chapter 2). 
Veno-occlusive function is assessed by determining the relationship between 
intracavernous flow rate and pressure. Two different inflow sources can be used: a 
rollerpump generating a fixed inflow rate (pump-cavernosometry) and an infusion 
set generating a fixed inflow pressure (gravity-cavernosometry) (Chapter 6). In 
pump-cavernosometry the flow rate required to maintain intracavernous pressure at 
suprasystolic pressure (maintenance flow) is the most reliable parameter of veno-
occlusive function. In a state of complete smooth muscle relaxation a flow to 
maintain of 3 ml/min is compatible with normal veno-occlusive function. In gravity-
cavernosometry, intracavernous pressure equals the pressure of the inflow source in 
normal veno-occlusive function (Chapter 6). If intracavernous pressure adjusts 
between 60 and 100 mmHg, moderate veno-occlusive dysfunction exists. In patients 
who are considered to be candidates for venous surgery cavernosography is 
performed to localize the sites of leakage. 
I) Penile angiography is utilized to define the anatomic pattern of arterial occlusive 
disease (Chapter 2). Satisfactory angiographic evaluation requires precise 
demonstration of the penile arterial supply from the aortic bifurcation to the tip of 
the penis. Patients with isolated lesions in the pudendal arteries are considered 
candidates for penile revascularization. 
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Changing concepts on the etiology of erectile dysfunction (from psychogenic to 
organic) and higher demands on male sexual function (from reproductive to 
recreative) have resulted in an substantial increase of impotent men who consult 
their urologist. There is no universally agreed-on diagnostic approach to the clinical 
evaluation of erectile dysfunction, because the technique and interpretation of the 
currently available diagnostic tests have not yet been sufficiently established. 
Therefore, consistency of diagnosis is disappointing. This study is an effort to 
critically evaluate currently available diagnostic techniques with the aim to design a 
practical diagnostic algorithm for the diagnosis of erectile dysfunction. 
In chapter 1 a short introduction on the psychosocial bearings of erectile 
dysfunction, the history of etiological concepts and definition of nomenclature and 
classification are given. In the second part of chapter 1 the aim of this thesis is 
outlined. 
In chapter 2 a review of the literature with respect to current diagnostic notions 
and techniques is given. 
Alternations of penile blood flow are thought to be the most frequent organic 
cause of erectile dysfunction. In 1985, penile duplex scanning was introduced by Lue 
as a non-invasive tool in the evaluation of penile circulation. In chapters 3, 4 and 5 
several aspects of penile duplex ultrasonography are studied. 
In chapter 3 the clinical applicability of duplex ultrasonography in combination 
with intracavemous administration of papaverine is investigated. For this study a 
black and white duplex scanner with an imaging frequency of 7.5 MHz is used. 
Validity and reproducibility of several parameters of penile duplex ultrasonography 
are assessed. It is concluded that the method has a learning curve and is operator-
dependent. Reproducibility of Doppler parameters, especially those that depend on 
the angle between the Doppler beam and the axis of bloodflow, is disappointing due 
to variables associated with the process of obtaining the tracings. Resistance index 
(RI) appears to be the most reliable parameter. 
Due to the dynamic state of penile blood flow following pharmacological 
stimulation, timing of measurement is critical. Psychogenic inhibition of papaverine-
induced erection turns out to be a source of misinterpretation. 
With the aim to define reference values, in chapter 4, the changes of penile blood 
flow in different phases of erection in men with normal erectile potency are 
described. For this study Doppler spectra are obtained in a strictly time-dependent 
manner following administration of 12.5 mg papaverine, using a color duplex 
scanner, with an imaging frequency of 5.0 MHz. The advantage of a color scanner is 
the ease of operation and reliability of the technique. Following intracavemous 
stimulation, the Doppler spectrum appears to alter according to a specific pattern 
indicating the different hemodynamic phases of erection as described in the 
literature. Based on the literature, peak flow velocity and acceleration time in the 
early post-injection phase are used to grade penile inflow and resistance index in the 
late post-injection phase to measure erectile response and therefore veno-occlusive 
function. 
A remarkable finding is that 30% of the volunteers does not show a full erectile 
response to pharmaco-stimulation at the time of duplex scanning. It is concluded 
that the failure to develop erection at the time of duplex scanning is due to 
psychogenic inhibition and that veno-occlusive dysfunction is the hemodynamic 
substrate of psychogenic inhibition. 
In chapter 5 the duplex ultrasonographically assessed hemodynamic effects are 
described of the most commonly used drugs for intracavemous stimulation 
112 Chapter 10 
(papavenne, phentolamine and Prostaglandine E l {PGE1}). It is concluded that 
papaverine m a dosage of 12.5 mg and PGE1 in a dosage of 10 μg are the most 
efficient drugs in terms of optimal arterial response and low risk of prolonged 
erection. Surprisingly, no differences are found between arterial responses in 
patients with erectile dysfunction and men with normal erectile potency. This finding 
demonstrates that men with vasculogenic ED are more likely to have veno-occlusive 
dysfunction than arterial insufficiency of the penile inflow tract Moreover, as noted 
before (Chapter 3-4) the results of studies described in chapters 3 and 4 are 
corroborated- the value of pharmacological testing of veno-occlusive function m 
conjunction with duplex ultrasonography is limited due to psychological factors. 
Patients' self-report on erectile response following duplex scanning represents a 
more versatile test for veno-occlusive function than measuring resistance index at the 
time of duplex scanning. 
Cavernosometry is the standard technique to study the cavernous veno-occlusive 
mechanism. In comparison to duplex scanning, the technique has the disadvantage 
of invasiveness. In cavernosometry venous outflow resistance is assessed by 
determining intracavernous flow rate of saline required to create and sustain 
erection. Since its introduction by Newman in 1964 different techniques and 
parameters have been described To date, it is generally accepted that 
cavernosometry should be performed only after complete relaxation of the cavernous 
smooth muscle. 
In chapter 6 two different techniques are compared The conventional method, 
pump-cavernosometry utilizing a rollerpump as inflow source and a new method, 
gravity-cavernosometry using an infusion set as inflow source Gravity-
cavernosometry has the advantage of simplicity and cost-effectiveness. It is 
concluded that: 1) in the majority of patients 50 mg papaverine is ineffective to 
produce complete smooth muscle relaxation at the time of cavernosometry. The 
authors recommend the use of a cocktail containing papaverine, phentolamine and 
PGE1 to obtain maximal smooth muscle relaxation, 2) of the parameters studied, 
the flow to maintain the cavernous pressure at a supra-systemic pressure (MF) 
appears to be the most reliable parameter of veno-occlusive function, 3) gravity-
cavernosometry may replace pump-cavernosometry. 
What is the place of neuro-urophysiological testing in the clinical evaluation of 
patients with E D ? In chapter 7 the neurogenic factor in ED is studied. A 
comprehensive neuro-urophysiological study in patients with ED but without 
clinically overt neurological disease is presented. The results are compared with the 
results obtained in healthy volunteers Comprehensive neuro-urophysiological testing 
includes measurement of Tibial Evoked Potential (ТЕР), Pudendal Evoked Potential 
(PEP), BulboCavernosus Reflex (BCR) and Urethro Anal Reflex (UAR). The 
combination of these measurements allows for localization of neurological lesions 
Thus, peripheral and central, as well as sacral and supra sacral lesions can be 
distinguished with the restriction that autonomic motor pathways cannot be assessed. 
Surprisingly, 47% of the patients shows one or more neuro-urophysiological 
abnormalities. These abnormalities are found in peripheral and penile sensory tracts 
more frequently in older patients This study suggests a causal relationship between 
ED and subclinical, age-related (penile) sensory disorders and corroborates the 
importance of penile sensibility in erectile capacity. 
Because the accuracy of current clinical techniques in assessing dysfunction of the 
cavernous body (veno-occlusive dysfunction or end-organ disease) appears to be 
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disappointing and because knowledge of the function of the end-organ is important 
in the selection of candidates for reconstructive vascular surgery, in chapter 8 the 
use of histologic examination of cavernous biopsies in the detection of end-organ 
disease is examined. Specifically, the relationship between smooth muscle and 
fibroelastic tissue in cavernous tissue samples obtained during autopsy is examined. 
It is concluded that in contrast to the electron microscopic studies described in the 
literature, light microscopic histomorphological assessment of cavernous smooth 
muscle cell content is not useful in the clinical diagnosis of erectile dysfunction. 
Moreover, the acquisition of cavernous biopsies for clinical diagnosis appears to be 
impracticable. Based on the studies outlined in chapters 2-8 in chapter 9 an 
algorithm for the diagnostic work-up of ED is presented 
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Het grote aantal nieuwe inschrijvingen op de andrologische poliklinieken en de vele 
reacties op recente televisie programma's met betrekking tot impotentie doen 
vermoeden dat erectie stoornissen (ES) vaker voorkomen dan algemeen wordt 
verondersteld. Oorzaken hiervoor zijn de grotere sexuele vrijheid, vergrijzing van de 
bevolking en betere mogelijkheden tot diagnostiek en behandeling. 
Voorwaarde voor het slagen van een behandeling is zorgvuldig onderzoek naar de 
oorzaak. Ofschoon er in de loop van de afgelopen jaren verschillende schema's voor 
onderzoek van ES zijn gepubliceerd, bestaat er nog geen universeel toegepaste 
klinisch-diagnostische beslisboom. Daarvoor zijn de bestaande onderzoektechnieken 
nog te weinig gestandaardiseerd en is de diagnostische waarde daarvan nog 
onvoldoende uitgekristalliseerd. Het gevolg hiervan is dat de diagnoses en daardoor 
de resultaten van behandeling in de verschillende centra slecht vergelijkbaar zijn. 
Het doel van dit proefschrift is om, naar aanleiding van een kritische evaluatie 
van veel gebruikte klinisch-diagnostische methoden, een praktische diagnostische 
beslisboom te ontwerpen. 
In hoofdstuk 1 en 2 wordt een inleidende literatuurstudie gepresenteerd: Men 
spreekt van ES, wanneer een normale coïtus door onvoldoende stijfheid van de 
penis onmogelijk is. De ernst van ES kan variëren van een afname van peniele 
stijfheid tot een complete afwezigheid van erectie. 
Door de eeuwen heen zijn ES een bron van vernedering en schaamte geweest. 
Kaplan zei in 1986: "de impotente man speelt zonder twijfel de meest trieste rol op 
het toneel van het menselijk drama". Opvallend is dat impotentie voor veel mannen 
nog zo'n beladen onderwerp is dat ze er met niemand over durven te praten. 
Aangenomen moet dan ook worden dat slechts een minderheid hulp zoekt. Uit 
spaarzaam bevolkingsonderzoek is gebleken dat ES een van de leeftijd afhankelijke 
aandoening is, die bij 2% van de mannen van 40 jaar en bij 25% van de mannen 
van 65 jaar voorkomt. Bij sommige ziekten, zoals b.v. suikerziekte en chronische 
nierziekte, komt impotentie frequenter en op jongere leeftijd voor. De gemiddelde 
leeftijd van mannen die op onze polikliniek hulp zoeken ligt tussen 50 en 60 jaar. 
Bij de opkomst van de psychoanalyse in het begin van deze eeuw verkeerde men 
in de veronderstelling dat psychologische factoren de belangrijkste rol spelen bij het 
ontstaan van ES. Door de ontwikkeling van nieuwe specifieke diagnostische 
technieken in de zeventiger en tachtiger jaren werd echter al snel duidelijk dat 
organische afwijkingen veel vaker voorkomen dan tot dusver werd aangenomen. 
In 1970 slaagde Karacan erin om de nachtelijke cyclus van peniele erectie te 
registreren. Hij vond bij 50% van zijn patiënten een afwijkend cyclus patroon 
duidend op organische oorzaken. Vandaag de dag wordt bij 80% van de impotente 
mannen een organische factor gevonden. Zoals zo vaak in de geschiedenis 
veroorzaakte een geniale vondst de definitieve omwenteling in het diagnostisch 
denken: Virag ontdekte in 1982 dat injectie van papaverine in het zwellichaam een 
erectie provoceert. Door Brindley werd vervolgens de basis gelegd voor de moderne 
diagnostiek op basis van farmacologische stimulatie van erectie. 
Kennis van het mechanisme van erectie en de storingen die daarin op kunnen 
treden is van belang om het aangrijpingspunt van de verschillende diagnostische 
technieken te kunnen begrijpen: Onder invloed van zenuwimpulsen of vaso-actieve 
stoffen (zoals bijv. papaverine, phentolamine, Prostaglandine E l ) ontspant het 
gladde spierweefsel, dat in de trabekels van het zwellichaam voorkomt. Hierdoor 
treedt er een verwijding op van de centraal in het zwellichaam verlopende slagader 
(arteria cavernosa) en neemt de bloedstroom naar het zwellichaam via de 
kurketrekker arteriën toe. De holten (sinusoiden) van het zwellichaam worden 
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gevuld. Wanneer de kurketrekker arteriën volledige open staan, wordt de bloeddruk 
van de lichaamscirculatie overgebracht op de sinusoiden van het zweilichaam. Door 
de hoge druk die nu in het zwellichaam heerst, worden de afvoerende aders (vena 
emissaria) tegen de stugge kapsel van het zwellichaam (tunica albugínea) 
dichtgedrukt, waardoor de afvloed van bloed wordt afgeknepen. De druk in het 
zwellichaam tijdens erectie is een resultante van bloeddruk in de arteria cavernosa 
en de weerstand van de afgeknepen venae emissariae (figuur la en b). 
Figuur 1 Doorsnede door hei zwellichaam in (a) rust en in (b) erectie 
In rust is de druk in het zwellichaam gelijk aan de veneuze bloeddruk, in erectie 
aan de arteriële bloeddruk. 
Theoretisch kan het erectie mechanisme op drie manieren verstoord worden: 
1) het proces van ontspanning van de trabekels wordt niet opgewekt, omdat de 
prikkeloverdracht vanuit het centrale zenuwstelsel naar de gladde spiercel verstoord 
is (neurogene of psychogene ES). Oorzaken: zenuwbeschadiging door ziekte, 
operatie, bestraling, letsel door ongeval of inwerking van giftige stoffen; veroudering; 
stress, angst of andere psychologische factoren; hormonale afwijkingen. 
2) er is onvoldoende vulling van het zwellichaam, door falende bloedaanvoer door 
vernauwingen in de slagaders (arteriogene ES). Oorzaken: roken; verhoogd bloedvet 
gehalte; aderverkalking; medicijnen; letsel door ongeval. 
3) het aangeboden bloed kan door het zwellichaam niet vast gehouden worden, 
door lokale afwijkingen aan de trabekels en/of kapsel van het zwellichaam (veneuze 
lekkage). Oorzaken: roken; medicijnen; stress, angst; veroudering; letsel door 
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ongeval; elk proces dat aanleiding geeft tot verbindweefseling van de trabekels, 
waardoor deze onvoldoende kunnen ontspannen om de afvoerende venen te kunnen 
afknijpen. 
Het onderzoek van de patiënt met ES is gericht op ontrafeling van de vaak in 
combinatie voorkomende factoren. In eerste instantie geschiedt dit door middel van 
een grondige vraaggesprek, waarin de symptomen en risikofactoren aan de orde 
komen. Het symptoom bij neurogene ES bestaat uit het onvermogen om enige vorm 
van erectie op het gewenste ogenblik te ontwikkelen. Bij arteriogene ES ontwikkelt 
een erectie zich maar langzaam en is onvoldoende stijf voor coïtus of masturbatie. 
Soms kan er na een uitgebreid voorspel of stimulatie wel een goede erectie 
ontstaan. Nachtelijke- en ochtenderecties zijn vaak wel van voldoende kwaliteit. Bij 
veneuze lekkage kan de erectie slecht gehandhaafd worden en is veelal onvoldoende 
voor coïtus. 
Op basis van het vraaggesprek wordt vervolgens een gericht aanvullend 
onderzoekprogramma afgesproken. Door de veelvoud van onderzoektechnieken staat 
de onderzoeker voor een moeilijke keuze: hoe uitgebreid moet de evaluatie zijn? Bij 
de keuze moet rekening gehouden worden met factoren zoals bijwerkingen van het 
onderzoek, de wensen van de patiënt m.b.t. behandeling, de kosten en de leeftijd en 
algehele gezondheid van de patiënt. Veel gebruikte onderzoektechnieken zijn 
weergegeven in tabel 1. 
Tabel 1 Onderzoektechnieken bij erectiestoomissen 
Registratie van nachtelijke erectie met behulp van de rigiscan (NPTR) 
Neuro-urofysiologisch onderzoek (NUFO) 
Psychologisch onderzoek 
Vasculair onderzoek (duplexscan, cavemosometrie, angiografie) 
Hormonaal onderzoek 
De in dit proefschrift onderzochte technieken zijn vet afgedrukt. 
Aan ES ligt vaak een vasculaire afwijking ten grondslag. In 1985 introduceerde Lue 
de duplex ultrasonografie in de diagnostiek van ES. Met behulp van duplex-scanning 
is het mogelijk om anatomische structuren en functionele parameters van de 
bloedstroom simultaan te onderzoeken. Toepassing van deze methode na inspuiting 
van een vaso-actief middel in het zwellichaam maakt beoordeling van de functie van 
de peniele circulatie mogelijk. In hoofdstuk 3, 4 en 5 worden verschillende aspecten 
van de peniele duplex ultrasonografie onderzocht. In hoofdstuk 3 wordt de klinische 
toepasbaarheid in combinatie met papaverine onderzocht. Voor dit onderzoek wordt 
een zwart-wit duplexscanner gebruikt. Reproduceerbaarheid en zeggingskracht van 
verschillende duplex parameters worden bestudeerd. Geconcludeerd wordt dat de 
methode een niet te verwaarlozen leerkurve heeft en sterk afhankelijk van de 
onderzoeker is. De reproduceerbaarheid van de Doppler parameters, in het 
bijzonder van parameters die afhankelijk zijn van de hoek die het Doppler signaal 
met de as van het bloedvat maakt, is teleurstellend tengevolge van meetfouten. 
Resistance index (RI) lijkt de meest betrouwbare parameter te zijn. 
Omdat de peniele bloedstroom na stimulatie met papaverine onderhevig is aan 
snelle veranderingen blijkt het moment van meting van invloed te zijn op de 
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uitkomst. Bovendien blijkt psychogene remming van de door middel van papaverine 
geïnduceerde erectie een belangrijke bron van misinterpretatie te zijn. 
Om referentie-waarden te kunnen definieren worden in hoofdstuk 4 de 
veranderingen van de peniele bloedstroom in verschillende fasen van erectie bij 
mannen met een normale erectiele functie gemeten. Bij dit onderzoek wordt een 
kleuren-duplex scanner gebruikt. Het voordeel van de kleurenscanner is dat de 
bloedstroom op het beeldscherm wordt afgebeeld, waardoor het bedieningsgemak en 
daardoor de snelheid en betrouwbaarheid van de metingen toenemen. De metingen 
laten zien dat het van de bloedstroom snelheid afgeleide Doppler spectrum na 
injectie van papaverine in het zwellichaam volgens een specifiek patroon verandert. 
Gebaseerd op gegevens in de literatuur worden de systolische bloedstroomsnelheid 
(peak flow velocity) en de acceleratie-tijd (acceleration time), gemeten in de vroege 
erectie fase, gebruikt als maat voor artenele instroom. De resistance index, gemeten 
in de late post-injectie fase, blijkt een goede maat te zijn voor de erectiele respons 
en daardoor een parameter voor veneuze lekkage. Opmerkelijk is dat 30% van de 
gezonde vrijwilligers geen erectie ontwikkelt tijdens het onderzoek. Geconcludeerd 
wordt dat het falen van de erectie toegeschreven moet worden aan psychogene 
remming ten gevolge van angst en spanning ten tijde van het onderzoek. 
Vergelijking van mannen mét en zonder erectie toont aan dat psychogene remming 
veneuze lekkage veroorzaakt. 
In hoofdstuk 5 worden de effecten van papaverine, phentolamine en 
Prostaglandine El (PGE1) op de peniele circulatie onderzocht. Geconcludeerd 
wordt dat 12,5 mgr papaverine of 10 μgr PGE1 door de goede artenele respons en 
het minimale risico op verlengde erectie de beste middelen zijn in combinatie met 
duplex scanning. Merkwaardig genoeg vinden wij geen verschillen in artenele 
respons tussen mannen mét en mannen zonder ES Aan de hand van deze gegevens 
dringt zich de conclusie op dat de kritische factor bij vasculaire ES in eerste 
instantie met een beperkte instroom maar een verhoogde uitstroom is. 
De resultaten van de studies beschreven in hoofdstuk 3 en 4 worden bevestigd: 
het effect van de geinjiceerde farmacologisch middelen op het veneuze afsluit-
mechanisme is sterk afhankelijk van psychogene factoren ten tijde van het 
onderzoek. Het veneuze afsluitmechanisme blijkt beter beoordeelbaar te zijn aan de 
hand van patient's eigen observatie van erectiele respons ná duplex scanning dan 
aan de hand van meting van de resistance index ten tijde van duplex scanning. 
Cavernosometne is de standaard techniek ter bestudering van het veneuze 
afsluitmechamsme. In vergelijking met duplex scanning is cavernosometne invasief: 
twee naalden moeten in het zwellichaam ingebracht worden. Tijdens 
cavernosometne wordt de veneuze weerstand van het zwellichaam bepaald door 
fysiologisch zout in het zwellichaam te pompen en de resulterende erectiedruk te 
meten. Sedert de introductie van cavernosometne in 1964 door Newman zijn 
verschillende methoden beschreven. Tegenwoordig bestaat er geen twijfel meer over 
dat cavernosometne alleen maar waarde heeft, wanneer de trabekels van het 
zwellichaam tevoren volledig ontspannen zijn. In hoofdstuk 6 worden twee 
verschillende methoden van cavernosometne vergeleken: de gebruikelijke methode, 
waarbij fysiologische zout door middel van een pomp in het zwellichaam gebracht 
wordt en een nieuwe methode, waarbij van de zwaartekracht gebruik wordt gemaakt 
om het fysiologisch zout te infunderen. Zwaartekracht-cavernosometrie is 
eenvoudiger en goedkoper dan pomp-cavernosometne. Geconcludeerd wordt dat: 
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1) bij het merendeel van de patiënten 50 mgr. papaverine niet voldoende is om 
volledige ontspanning van de trabekels te bewerkstelligen ten tijde van 
cavernosometne. 
2) de hoeveelheid fysiologische zout per tijdseenheid, toegediend om het 
zwellichaam op een druk boven de lichaamsbloeddruk te houden (onderhoudsflow of 
maintenance flow), de meest betrouwbaar maat is voor de functie van het veneuze 
afsluitmechanisme. 
3) zwaartekracht-cavernosometne dezelfde informatie kan verschaffen als pomp-
ea ve rnosometne. 
Welke plaats heeft neuro-urofysiologisch onderzoek in de klinische diagnostiek van 
ES? In hoofdstuk 7 wordt de neurogene factor van ES bestudeerd aan de hand van 
uitgebreid neuro-urofysiologisch onderzoek bij mannen met ES zonder symptomen 
van neurologische afwijkingen. De resultaten worden vergeleken met de resultaten 
verkregen bij gezonde vrijwilligers. Uitgebreid neuro-urofysiologisch onderzoek 
bestaat uit meting van Tibialis Evoked Potentiaal (ТЕР), Pudendus Evoked 
Potentiaal (PEP), BulboCavernosus Reflex (BCR) en Urethro-Anaal Reflex (UAR). 
Door combinatie van deze metingen is het mogelijk de lokalisatie van de 
neurologische afwijking te bepalen. Zodoende kunnen perifere en centrale en 
sacrale en suprasacrale letsels onderscheiden worden. Het onderzoek vindt zijn 
beperking in het feit dat de motorische bezenuwing van het zwellichaam met 
onderzocht kan worden. Tot onze verrassing bleek 47% van de patiënten neuro-
fysiologische afwijkingen te vertonen. Deze bevindingen tonen het verband tussen 
ES, leeftijd en afwijkingen aan de peniele gevoelszenuwen aan en onderstrepen het 
belang van het peniele gevoel voor erectiel vermogen aan. 
Omdat het vermogen om dysfunctie van het zwellichaam (ziekte van het eind-
orgaan) met behulp van de beschreven diagnostische technieken te diagnostiseren 
beperkt is en omdat kennis van de functie van het eind-orgaan belangrijk is voor de 
selectie van patiënten voor operatieve behandeling wordt in hoofdstuk 8 de 
bruikbaarheid van histologisch onderzoek van biopten van het zwellichaam 
onderzocht. Hiertoe wordt de verhouding tussen glad spierweefsel en bindweefsel 
componenten in de trabekels onderzocht. Geconcludeerd wordt dat, in tegenstelling 
tot elektronen-microscopisch onderzoek, hcht-microscopisch onderzoek niet 
bruikbaar is voor klinische diagnostiek van ES. Bovendien blijkt het verwerven van 
biopten van het zwellichaam op praktische bezwaren te stuiten. 
Gebaseerd op de gegevens beschreven in de hoofdstukken 2-8, wordt in hoofdstuk 
9 een beshsboom voor de klinische diagnostiek van ES voorgesteld. Ofschoon het 
doel van deze beslisboom een op iedere individuele patient gerichte behandeling is, 
blijkt in de praktijk dat het merendeel van de patiënten "slechts" symptomatisch 
behandeld kan worden. Desalniettemin is het onze ervaring dat de tevredenheid 
over de behandeling in sterke mate afhankelijk is van de juistheid van de diagnose. 
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Stellingen behorende bij het proefschrift 
RECENT PROGRESS IN THE DIAGNOSIS OF ERECTILE 
DYSFUNCTION 
door 
Eric J.H. Meuleman 
Nijmegen, 6 december 1991 
1. Een spontane erectie is nooit weg. 
2. Peniele pharmaco-duplex scanning is het onderzoek der keuze, wanneer een 
vasculaire oorzaak voor de erectiele dysfunctie wordt vermoed. (Impotence 
researchers do it ultrasonographically). 
3. A pharmacologically-induced positive erectile response does not rule out 
vasculogenic erectile dysfunction. 
4. Het organisch substraat voor psychogeen geinhibeerde erectie is veno-
occlusieve dysfunctie 
5. Voor de patient met erectiele dysfunctie geldt dat zijn tevredenheid over de 
behandeling sterk gerelateerd is aan de grondigheid van de diagnostiek. 
6. In men, sperm maturation is independent of epididymal transport. 
Therefore, in an obstructed epididymis the more proximal sperm has the 
highest fertilizing capacity. (Silber) 
7. Extreme Oligospermie in een normogonadotrope man met een normaal 
testiculair volume doet een obstructieve oorzaak voor infertiliteli vermoeden. 
8. Bij de behandeling van de varicocele verdient embolisatie de voorkeur 
boven chirurgische hgatie van de vena spermatica. 
9. 2b or not 2b, that's a question in staging testicular cancer. 
10. Prostaatechografie levert tot op heden nog geen bijdrage tot de diagnose 
"chronische prostatitis". 
11. Er bestaat geen absolute relatie tussen het niveau van een dwarslaesie en 
de bevindingen bij urodynamisch onderzoek. 
12. Voor optimale patiëntenzorg in een unit voor erectiestoomissen is een 
goede multidisciplinaire samenwerking noodzakelijk. 
13. In de bergen moet men ondanks het veelvuldig toegewenste "Grüss Gott" 
stevig met beide benen op de grond blijven staan. 
14. De schoonheid van de Nijmeegse waalkade zou aanzienlijk toenemen 
wanneer deze permanent voor gemotoriseerd verkeer gesloten zou zijn. 
15. De vervanging van de "Belgenmop" door de "Duitsermop" luidt een nieuwe 
fase in verwerking van het oorlogsverleden in. 
16. Zowel voor de disk-jockey als voor de zelf-injectie patiënt geldt: hoedt U 
voor een botte naald. 
17. Handhaving van een leefbaar milieu is alleen mogelijk als iedereen zich 
beperkingen oplegt. Deze beperkingen moeten centraal afgedwongen 
worden. 
18. De niet-gemotoriseerde verkeersdeelnemer doet er verstandig aan een 
verkeerslicht slechts als adviesorgaan te beschouwen. 
19. Het cynische gezegde "houtskool bloedt niet" is een aansporing tot gericht 
gebruik van diathermische apparatuur tijdens een chirurgische ingreep. 
20. It's better to burn out than to fade away.(Young) 



